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ABSTRACT

Annually, over 5.7 million Americans are diagnosed with two IVD-associated
pathologies: IVD herniation (IVDH- a mechanical disruption of the concentric fibrous
layers of the annulus fibrosus (AF))) and degeneration (IVDD- a multifactorial process
which initiates within the inner gelatinous core (NP), and results in a biochemical
degradation of NP tissue), with over 2.7 million requiring surgical inteventions.1,2
Although both underlying pathologies are different, quite often they both lead to a decrease
in IVD height, impaired mechanical function, and increased pain and disability. These pain
symptoms affect approximately 80% of the adult population during their lifetime with
estimated expenditures exceeding $85.9 billion.3,4
Current surgical procedures for IVDH and IVDD are palliative and suffer from
drawbacks. While they are performed to address patient symptoms, they fail to address the
underlying pathology of a defect remaining within the subsequent layers of the AF. An
effective AF closure/repair device in conjunction with a less aggressive discectomy for
IVDH and/or NP arthroplasty for IVDD, may result in improved patient outcomes,
decreased pain, and provide fewer revision surgeries via lower re-herniation and expulsion
rates.5,6 Therefore, an intact AF must be re-established to prevent implant expulsion or reherniation, thus addressing the two major spinal pathologies directly associated with an
IVD.
Currently within the medical device market, no tissue engineering biomaterials are
available for AF closure/repair. Current market AF closure devices (Intrinsic Barricaid®,
Anulex X-Close® Tissue Repair System, and Anulex Inclose® Surgical Mesh System) are
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synthetic materials focused solely on preserving and reinforcing the native tissue and lack
efficient strategies for implantation, fixation, and regeneration. Therefore, there has been
an increase in tissue engineering and regenerative therapeutic approaches aiming for
structural and biological AF repair investigated over the last decade using in vivo and in
vitro experimentation. It is proposed that the optimum AF tissue engineering scaffold
should reproduce the architecture, and the mechanical properties of the native human AF
tissue.7 Recent articles illustrate several novel suture, seal, and barrier techniques currently
under development, resulting in an increasing attention at scientific workshops and
conferences.8–15
To develop a tissue engineering biomaterial that is suitable for AF closure it must
meet the following criteria: (1) mimic the structural angle-ply architecture of the native
AF, (2) withstand static and dynamic mechanical properties mimicking the native
functional characteristics, and (3) express cytocompatibility while promoting tissue
regeneration. Current biomaterials growing attention in the tissue engineering academic
field, electrospinning, polymers, glue, silk scaffolds, and honeycomb-scaffolds, require
complex manufacturing procedures and typically work to address two of the three criteria
(mimicking the biological and structural characteristics).5 Although the mechanical
advantage of closing annular defects to retain NP material seems intuitive, only recently
have AF closure devices begun to examined in human cadaveric or animal tissues for their
ability to withstand in situ IDP or flexibility testing.16 Therefore, the use of decellularized
tissue from a xenogeneic source is ideal due to its advantage of maintaining native
extracellular matrix (ECM) while also removing all potential harmful xenogeneic factors.
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We propose to address all three criteria with the development of a biomimetic
angle-ply annulus fibrosus patch comprised of decellularized porcine pericardium. Porcine
pericardium was chosen due to its native type I collagen content, mechanical strength, and
cytocompatibility. The objectives of this research were to investigate the development of a
biomimetic patch, consisting of decellularized porcine pericardium, to biologically
augment AF repair by (1) characterizing the micro-architecture of the multi-laminate angleply AF patch, (2) evaluating the mechanical properties through static and dynamic tensile
loading and impact resistance of IDP, and (3) evaluating the cytocompatibility of the patch
using a healthy alternative cell source for AF tissue regeneration.
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CHAPTER I
LITERATURE REVIEW
BACKGROUND
Low back pain (LBP) affects approximately 80% of the adult population during
their lifetime with estimated expenditures exceeding $85.9 billion.3,4 Patients suffering
from LBP often experience a diminished quality of life. Within the United States of
America, LBP is the most common cause of activity limitation in people under the age of
45, the 2nd most frequent reason for doctor visits, the 5th leading cause of hospital
admission, the 3rd most common surgical procedure, and the most common cause of jobrelated disability leading to days missed on the job.2,17–19 Although LBP is multifactorial;
LBP can originate from intervertebral disc (IVD) pathologies. Annually, over 5.7 million
Americans are diagnosed with two IVD-associated pathologies: IVD herniation (IVDH- a
mechanical disruption of the concentric fibrous layers of the annulus fibrosus (AF))) and
degeneration (IVDD- a multifactorial process which initiates within the inner gelatinous
core (NP), and results in a biochemical degradation of NP tissue), with over 2.7 million
requiring surgical intervention.1,2 Although both underlying pathologies are different, quite
often they both lead to a decrease in IVD height, impaired mechanical function, and
increased pain and disability.
INTERVERTEBRAL DISC ANATOMY, PHYSIOLOGY, AND PATHOLOGY
An IVD links adjacent vertebral bodies together to provide mobility and stability
to the spine. The IVD’s function is to support compressive loads arising from body weight
and muscle forces while allowing for motion. There are 23 IVD’s in the human spine: 6
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cervical, 12 thoracic, 5 lumbar. The IVD is divided into three distinct regions as seen in
Figure 1: nucleus pulposus (NP), annulus fibrosus (AF), and hyaline cartilaginous
endplates.20

Figure 1: Intervertebral Disc Overview21
During early development, IVD’s have some vascular supply to the cartilage
endplates and AF, but these supplies quickly deteriorate leaving nearly no direct blood
supply in healthy adults.22 Thus, making these the largest, avascular structures in the human
body. IVD’s are composed of three major constituents: water, fibrillar collagens, and
aggrecan (cartilage-specific proteoglycan). The proportion and organization of these
components vary considerably with position across the IVD, for example, the NP has a
higher concentration of aggrecan and water, but a lower collagen content than other regions
of the IVD.23 Collagen proportions change based on location in the IVD, with the NP
containing only type II collagen while both types I and type II are found in the AF.24
The NP is the central proteoglycan and collagen Type II rich core distributes
intradiscal pressure arising from applied compressive loads. The NP is comprised of a large
aggregating proteoglycans, which contains a protein core. Up to 100 highly sulphated
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glycosaminoglycan (GAG) chains, principally chondroitin and keratin sulphate, are
covalently attached to a core protein.25 The chains are long, linear carbohydrate polymers
that have a net negative charge under physiological conditions. This negative charge
attracts positively charged sodium ions which in return lures water molecules via osmosis.
Research studies have proven a negative correlation between age and degeneration to the
amount of water and GAGs present within the NP.26 As GAGs begin to diminish overtime,
it is replaced with fibrocartilage. The presence of fibrocartilage found in IVDs as GAGs
diminish is a protective adaptation to physiological conditions.
The AF consists of circumferential exterior collagen sheets and is an essential
constituent of the intervertebral joint. The AF is comprised of approximately 15-25
collagen sheets (lamellae), per IVD, which encompasses the NP.27 These lamellae are
comprised of type I collagen fibers that are aligned in alternating patterns of ± 30 degrees
to the horizontal axis of the spine.28 The AF can is divided into three layers: peripheral,
intermediate, and inner regions. The annulus fibers are found to be thicker and more
numerous anteriorly than posteriorly while the posterior fibers express a more parallel
alignment.29 The bundles of fibrous cartilage (multi-layers) runs obliquely from one
vertebral body to the next to anchor the IVD to the cartilaginous endplates.
The hyaline cartilaginous endplates allow for nutrient supply to the IVD. Since
IVD’s are avascular structures, they are dependent on the endplates for nutrient diffusion.
By the age of eight, the cartilaginous endplates lose their blood supply, leaving holes from
blood vessels that allow for the diffusion of metabolites.29 These holes which are essential
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for the supply of nutrients also cause structural deficiencies (weakness) to the endplate
structure.
CLINICAL SIGNIFICANCE OF INTERVERTEBRAL DISC DISEASES
In a clinical setting, two relevant pathologies directly affect the IVD: IVD
herniation (IVDH) and IVD degeneration (IVDD). An IVDH is referred to as a “herniated
disc”, “bulging disc”, or “slipped disc”. IVDH as a consequence of traumatic (quick jolting
motion), typically results in painful circumstances for the patient via nerve root
impingement. As an IVDH begins to form, the AF begins to degrade and rupture progress
radially through its layers. This results in a loss of IVD height, a decrease in IDP, and in
many cases contributes significantly to LBP. This defect provides a pathway for the NP to
bulge or migrate beyond the confines of the AF layers that can apply pressure to a nearby
nerve within the spinal canal, “pinched nerve.” The applied pressure leads to irritation of
the nerve which depending on the level of intensity may lead to a radicular pair. Radicular
pain is a pain that radiates to the extremities of the body, i.e. arm and legs, which travels
directly along the course of a spinal nerve root. A “pinched nerve” may lead to symptoms
of dull/sharp pain in the lower back, muscle spasms/cramping, sciatica, leg weakness,
and/or loss of leg function. Although it is important to express, not all patients who develop
an IVD herniation experience symptoms of pain.
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Figure 2: Stages of Disc Herniation (IVDH)30
There are four stages of IVD herniation as seen in Figure 2: Stage 1) Annular tear:
IVD is intact, but a small tear in the outer layer (without herniation), Stage 2) Prolapse: the
form of position of the IVD changes with some slight impingement into the spinal canal
(i.e. bulge or protrusion), Stage 3) Extrusion: the gelatinous core of the NP breaks through
the

collagen

sheets

of

the

AF

but

remains

within

the

IVD,

Stage

4)

Sequestration/Sequestered Disc: the NP breaks through the AF and lies outside the IVD in
the spinal canal.31 The most frequently affected IVDs via IVDH are IVDs with the most
substantial range of motion and/or axial loading forces: L3-4, L4-5, L5-S1.
IVDD is a prevalent musculoskeletal disease seen through the aging population.
IVDD occurs via a multifactorial process that results in biochemical degradation of NP
tissue, a decrease in IVD height, a decrease in IDP, and loss of mechanical function. IVDD
is linked to multiple factors in the initiation and progression of the disease: aging, poor
nutrient supply, loading conditions, and hereditary factors.32–38 Consistent IDP changes of
the NP result in assuage of the posterior AF. This is identified as part of the aging process
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after 45 years of age, thus resulting in total annular lamellae disorganization by the age of
80.39,40 A research study showed through magnetic resonance imaging (MRI) 20% of
patients tested over 45 years of age have an IVD bulge or IVDD, and nearly 60% of patients
over 65 years of age had IVDD.41
IVDD is a loss of both hydraulic and viscoelastic properties of the IVD through 1)
a decrease in the water content and, therefore, a reduction of the preloading effect of the
NP, 2) a decrease in the elastic collagen tissue in the annulus with replacement of large
fibrous inelastic bands, and 3) cartilage degeneration in the endplates.29 IVDD is
characterized by changes identified in the cellular microenvironment, loss of proteoglycan,
loss of IVD height, tears of AF tissue, spinal stenosis, herniated discs, neoinnervation,
hypermobility, and inflammation.42–45
Degeneration is diagnosed on a grading scale of 0-4 of the IVD (Figure 3)and can
be referred to the degeneration of the facet joint: Grade 0) no changes in the physiological
IVD, Grade 1) joint space narrowing, Grade 2) narrowing in addition to sclerosis or
hypertrophy, Grade 3) severe osteoarthritis in addition to beginning narrowing, sclerosis,
and osteophytes, and Grade 4) advanced osteoarthritis in conjunction with hypertrophy,
narrowing, sclerosis, and osteophytes.46
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Figure 3: Stages of Disc Degeneration (IVDD)47
The level of degeneration has a correlating effect on the amount of IDP observed
by the IVD. The mean IDP showed a statistically significant difference between each grade
of degeneration, with IDP reduced with increasing levels of degeneration.48 The IDP in
the L4-L5 IVD measured in a patient with a grade 0 degeneration presented a mean of
0.091 [MPa] while a patient with a grade 4 degeneration displayed a mean IDP of 0.010
[MPa].48
CURRENT TREATMENTS OF INTERVERTEBRAL DISC DISEASES
Treatment plans for LBP are dependent on the patient’s history and the
type/severity of pain. Until recently, clinicians believed pain due to herniation would
resolve on its own without surgical intervention (i.e. spontaneous resorption of the
herniation). However, despite a temporary reduction in pain, a recent study showed that
when herniation’s are not treated, a resurgence of the pain does in fact occur. The study
investigated the course of LBP in a general population of 2000 people aged 30-50 years
over a five year period. The study found that for more than 33% of people who experienced
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LBP, the pain lasted for >30 days, and out of these 33% of patients, only 9% were painfree five years later.49
The treatment method utilized by a physician is often dependent on the type of
injury of the patient, with IVDD and IVDH requiring different treatment approaches.
IVDH treatments typically begin with bed rest, NSAIDs, and pain-medications. Sometimes
physical therapy (PT) may also be prescribed to improve the patients’ symptoms. However,
if symptoms persist, epidural injections of corticosteroids to reduce the nerve irritation and
facilitate healing may be assessed. If a patient is not responding to 6-12 weeks of
conservative conventional treatments, surgical intervention is often considered. For
patients suffering from LBP, a microdiscectomy, and/or laminectomy may be performed.
Within the United States, (U.S.) lumbar discectomy is the most frequently completed
procedure to repair an IVDH, with over 300,000 operations performed annually.,50 with an
associated direct cost of approximately $3,445 per case.51
The surgical approach to a discectomy procedure, “minimal or aggressive,” is based
on the surgeons’ personal preference. Both techniques have favorable and unfavorable
results, pros and cons. The objective of the surgical procedure, to be considered a complete
success, provides the maintenance of the patients’ IVD height, and experiences low
reoccurrences of IVDH. By maintaining the patient’s IVD height, this provides better
patient outcomes. A “minimal” discectomy maintains the IVD height, but is at an increased
risk of reherniation. While an “aggressive” discectomy reduces the reoccurrence of
herniation’s, it is linked with IVD height collapse.52–54 In both surgical approaches, there
is the partial removal of the protruding herniated NP tissue and decompression of the neural
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elements. During the procedure, a laminotomy/laminectomy, a small piece of the vertebrae
removed, may need to be performed to provide access to the herniated fragments. This
laminotomy permits a more advantageous visualization for the surgeon of the herniated
fragments of the IVD. Consequently, by removing the herniated IVD fragments via
discectomy, an open pathway (defect) remains through the layers AF, which provides a
path of least resistance for recurrent herniation’s to occur. Regardless of surgical approach,
an average IVD height loss of 25% has been reported after a discectomy, which is
associated with increased back pain and disability.50 Various studies have shown that
reoperation rates range from 9-25% at 4 and 10 years post-operatively,55–59 which results
in direct costs ranging from $2.5k for conservative management to 35k for surgical reintervention, respectively per case.60,61 It is imperative to express, current discectomy
procedures are not directed to treat the damaged IVD, but rather to alleviate patients’
symptoms that may result in further aggravation of existing damage.10,62,63 Since
discectomies are still the most performed spinal surgical procedure worldwide and mainly
affects the employed population, the resulting socio-economic consequences are
significant.64
Alternatively, IVDD is often managed with over-the-counter pain medications (i.e.
NSAIDS), and applying ice/heat to the affected area. More aggressive treatments include
physical therapy (PT), chiropractic manipulation, electrical stimulation, massage, and last
surgery. With surgical interventions, surgical treatments of IVDD are focused towards
treating symptoms experienced by the patient rather than restoring native structure and
function.
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Currently, two IVDD surgical procedures are performed: spinal fusion and total
disc replacement (TDR). Both procedures have an objective to preserve the IVD height as
seen in Figure 4. The traditional procedure, often considered as the “gold standard”
surgical treatment, for an IVDD, is the generation of a bony fusion between two vertebral
bodies to reduce spinal instability and minimize pain.65 Shortcomings of a fusion procedure
include adjacent segment degeneration and other complications; thus, it is typically
employed as a last resort option. Spinal fusions are approached from either the posterior or
anterior position. While historically the posterior approach has been used, the anterior
approach allows the surgeon to leave an IVD space that more likely will result in the patient
having greater pain relief.66 The cost of spinal fusion typically ranges between $80k to
$150k per case; a significantly greater cost as compared to a discectomy procedure.

Figure 4: IVDD End-Stage Devices Used for Surgical Repair.67 Left) Lumbar Fusion
Device. Right) Lumbar Artificial Disc Replacement
The more contemporary surgical procedure, TDR, consists of the removal of the
damaged IVD, but maintenance of motion is achieved by the use of a prosthetic implant.
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However, during a TDR only one of the three joints of the vertebra is replaced, thus limiting
the range of motion.68 Long-term clinical data is still needed to validate the efficacy of
TDR.69 Due to adjacent segment disorders seen with spinal fusions and lifetime of TDR
devices revision surgery is an important factor that must be addressed with these clinical
procedures. Clinical outcomes have shown that patients undergoing revision fusion surgery
exhibited significantly higher rates of unfavorable discharge, prolonged length of stay at
the hospital, high-end hospital charges, neurologic complications, pulmonary embolism,
wound

infections,

wound

complications,

and

gastrointestinal

and

respiratory

complications.70
REPAIR OF THE IVD
With the short-term lifespan of mechanically assisted devices and limitations of
patient’s mobility, repair and/or regeneration of the IVD is needed to restore it to its healthy
native state. A functional AF must be capable of withstanding the mechanical static and
dynamic tensile, burst, and impact loading saw in a healthy IVD. To accomplish this
ideology, it is advantageous and obligatory to have an intact AF to allow for native
physiological and functional capabilities.
Current surgical procedures for IVDH and IVDD are palliative and suffer from
drawbacks. Depending on the amount of herniated material removed, patients undergoing
discectomy can be at an increased risk for re-herniation.55,59 Treatments for IVDD, as stated
above, are end-stage surgical interventions that could benefit from an early stage solution,
such as nucleus arthroplasty. Current research is being conducted on developing an
artificial NP, which would be used for replacing the degenerated native material; however,
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the defect in the AF would remain after implantation and migration, respectively.
Therefore, in both clinical scenarios it would be advantageous and obligatory to have an
intact AF to prevent re-herniation. Accompanying techniques that treat the damaged AF
are now increasingly recognized as mandatory to prevent re-herniation, to increase the
potential of NP repair, and to confine NP replacement therapies that target early-stage
IVDD and IVDH.71
These shortcomings and drawbacks of current surgical procedures constitutes a
need in which the tissue engineering discipline may be applied to repair the native IVD.
ANNULUS FIBROSUS STRUCTURE
The AF is comprised of circumferential exterior sheets (lamellae) comprised of
collagen type I and is an essential constituent of the intervertebral joint. The AF is divided
into three layers: peripheral, intermediate, and inner segments. The annulus fibers are found
to be thicker and more numerous anteriorly than posteriorly while the posterior fibers
express a more parallel alignment.29 The bundles of fibrous cartilage (multi-layers) runs
obliquely from one vertebral body to the next to anchor the IVD to the cartilaginous
endplates. The formation of the AF begins at the mesoderm germ layer, one of the three
primary germ layers in the early stages of embryonic development. The middle
embryological germ layer, mesoderm, forms the mesenchyme that during embryogenesis
develops the AF.72 The composition of the AF is comprised of four main elements: water,
collagen, proteoglycans, and non-collagenous proteins. The physiological classification by
percentage of these elements is as follows: water (65-90%), collagen (50-70% dry weight),
proteoglycans (10-20% dry weight), and non-collagenous proteins (i.e. elastin) (5-25%).73–
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Within the internal portions of the AF, the layers are less hydrated than the NP and more

widely dispersed in comparison to the exterior region of the AF.76 The interior AF also
consists of a more substantial amount of GAGs in comparison to the exterior region of the
AF: aggrecan and versican.77–81 Small proteoglycans are found in greater amounts in the
internal region: biglycan, decorin, fibromodulin, and lumican.82–84 The distribution of type
I and II collagen also fluctuate based on location within the AF. The exterior lamellae
consist purely of type I collagen, but as you move interiorly toward to the NP, overall type
II collagen percentage increases as type I collagen percentage decreases. The internal AF
is mainly composed of type II collagen, although other collagen types such as III, V, VI,
IX, and XI were detected within the inner AF.85
The highly organized structure of the AF results in a complex anisotropic behavior,
with tensile, compressive, and shear properties differing in the axial, circumferential, and
radial directions.74,86,87 The AF is comprised of collagen sheets (lamellae) with
approximately 15-25 lamellae, per IVD,27 which the fibers are aligned in alternating
patterns of ± 30° to the horizontal axis of the spine, as seen in Figure 5.28
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Figure 5: Annulus Fibrosus Lamellae. Arranged in alternating patterns
between subsequent layers.88
The composition of the lamellae is filled with proteoglycans and interspersed with
elastin fibers.89 In the exterior AF, long elastic fibers are present within the lamellae,
running parallel to each other in the same direction as the collagen sheets. However, within
the internal AF, the elastic fibers are present between adjacent lamellae as well as increased
regular organization within the lamellae.90 The spaces located between the separate layers
of the AF are called interlamellar septae, and they contain proteoglycan aggregates, and a
complex structure of linking elements creating interlamellar cohesion.73,91,92 The ends of
the collagen sheets run obliquely from one intervertebral body to the next to attach/secure
the IVD to the endplates.
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MECHANICAL PROPERTIES OF NATIVE ANNULUS FIBROSUS
Mechanically, the interior AF region is subjected to higher IDP generated from the
NP as opposed to higher tensile forces exerted on the exterior region.93,94 Together these
fiber networks couple adjacent lamellae together allowing them to work co-operatively
during dynamic loading and prevent separation of lamellae during torsional compressive
loading.95
The posterolateral location of the AF experiences the highest frequency of layer
interruption from various mechanical forces.96,97 This region is also where the highest
stresses are observed during loading,98 and where annular tears, fissures, protrusions,
extrusion, and/or sequestrations are known to develop.99 Table 1 illustrates the mechanical
characteristics of the native AF.
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Table 1: Mechanical Characteristics of the Native AF Tissue

Property
Dimensions L4/L5 IVD

Value
IVD Width: 30.4 ± 4.5 mm100
NP Width: 19.3 ± 2.9 mm100
Anterior AF: 20.5% (total IVD)100
Posterior AF: 15.6% (total IVD)100

Burst Strength

Slit (6 mm vertical): 0.93 [MPa]16
Circular Opening (3 mm): 0.64 [MPa]16

Ultimate Tensile Strength

Anterior: 1.7 ± 0.8 [MPa]101
Posterior: 3.8 ± 1.9 [MPa]101

Elastic Modulus

Anterior: 7.2 ± 3.1 [MPa]101
Posterior: 27.2 ± 10.2 [MPa]101
Overall 12-24 [MPa]102

Tensile Fatigue

1043 cycles at 2.3[MPa]101
10,000 cycles at 1.7 [MPa]101

HEALING POTENTIAL OF THE ANNULUS FIBROSUS
To unlock the potential for AF regeneration, the native healing potential needs to
be addressed. The intrinsic capacity of the AF to cope with damage or degenerative
pathological changes have been studied in several animal trials.103–112 Key and Ford studied
the healing capacity of three different types of posterior annulus lesions in a canine model:
square annular window, transverse incision, and puncture with 20 gauge needle (0.91
mm).107 During post-operative procedures, the lesions were initially filled with
extravasated blood, fibrin, bone, and cartilage debris. These were gradually replaced by a
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thin layer of fibrous tissue at later time points (up to 22 weeks). While the larger damaging
lesions (window and incision lesion groups) developed slowly towards IVD protrusion, the
lesions that were generated by needle puncture revealed nothing irregular and the site of
puncture was unidentifiable after 22 weeks. This study was contradicted however using
rabbit IVDs as an organ culture model. The needle puncture showed immediate and
progressive mechanical and biological consequences that could lead to degenerative
modeling if longer time points were observed.113
Smith identified the healing process of the AF occurs in three different phases. In
the 1st phase, the outer AF begins to heal. This is caused by a proliferative reaction in the
fibrous tissue spreading from the lateral parts of the wound to the medial parts. During the
2nd phase changes occur in the inner annular fibers. The lateral parts of the interior AF
layers gradually heal by a slow appositional spread in the medial direction. The process
normal begins after a few weeks, but can last up to one-year post-operatively. During the
3rd phase, an increase in the number of collagenous fibers found within the NP tissue, which
has remained in the AF wound tract, become increasingly dense.112
Although many hypotheses has been formed on what leads to the limited intrinsic
healing capability of the AF, many contributing factors remain unknown. One of those
reasons may be the fact that exterior repairs are not matched, or insulated to the demands
of progressive recruitment of fibers to a tensile force.114,115 Nevertheless, no matter the
underlying reason of why, the limited intrinsic healing capability of the native AF
negatively correlates with the success rates of discectomies and NP replacement
therapies.71

17

ANNULUS FIBROSUS CLOSURE TECHNIQUES

COMMERCIALLY AVAILABLE PRODUCTS
With tissue engineering, medical devices still in the primitive stage, mechanical
closure of the AF is the most effective closure technique currently available on the market.
It has been proposed that improved annular closure procedures may reduce IVD reherniation, and reduce the need for spinal fusion. The most straight-forward solution is per
operative suturing of the AF defect. However, suturing does not account for missing AF
tissue and may not be strong enough to resist changes of the IDP generated by the NP tissue
under different loading regimes. Efficacy and efficiency of suturing the AF have been
studied by Ahlgren et al. in an animal study of an ovine model. It was reported that sutured
IVDs showed a tendency towards stronger healing, but the results were not statistically
significant.103 As the investigation of an AF closure device continues, Johannes Bron states,
the clinical durability the eventual arbiter of technological value.71
A diversity of medical devices have been designed or are currently being studied to
preserve, repair, and reinforce the AF. The following devices are currently marketed for
the proposed use in AF closure after a discectomy to reduce the risk of re-herniation.
Anulex Technologies, Inc. has developed two devices: Xclose Tissue Repair System and
Inclose Surgical Mesh System. Intrinsic Therapeutics developed the Barricaid Annular
Reconstruction Device. Lastly, Magellan Spine Technologies, Inc. has developed the Disc
Annular Repair Technology (DART) System. Table 2 illustrates a comparison of AF repair
devices currently available on the market.
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Table 2: Comparison of AF Repair Devices Currently Available on the
Market
Product

Competitors
Description

Company

Limitations
Long-term (>2 years) results showed no significant
Barricaid Annulus
Polyethylene Terephthalate reduction in reherniation rates. Potential issues with
Intrinsic Therapeutics
Closure Device
and Titanium Bone Anchor migration of device. Device lacks ability to regenerate
and remodel with host tissue
In vitro studies demonstrated the Anulex technology
was unable to with stand high physiologcially relevant
Xclose Suturing System Anulex Technologies Polyethylene Terephthalate loads. Device lacks regeneration capabiliteis. In vivo
studies showed migration, extrusion, and unable to

Inclose Surgical Mesh Anulex Technologies Polyethylene Terephthalate

Suture

Various

Nylon, Polyester, PVDF,
and Polypropylene.

Disc Annular Repair
Technology (DART)
System

Magellan Spine
Technologies, Inc.

Polyetheretherketone
(PEEK)

maintain disc space2
In vivo studies showed migration, extrusion, and
unable to maintain disc space2
Technically demanding due to limited space and
1

potential injury to neurological structures. Single
sutre low tensile strength.
No studies currently published in the peer-reviewed
medical literature to support the efficacy and safety of
the DART system, or that it will improve health
outcomes for use in individuals for any indication

The Xclose Tissue Repair System received a 510(k) clearance on August 7th, 2006.
The Xclose system consists of non-absorbable, synthetic, poly(ethylene terephthalate)
surgical sutures modified with toggle anchors. The FDA labeled indications state the
system is used for soft tissue approximation in general and orthopedic surgery procedures.
The use of an AF repair was later deemed as outside the scope of the 510(k) clearance. The
FDA required the manufacturer to submit a premarket approval application (PMA), in
conjunction with clinical data from an investigational device exemption (IDE) study.
Xclose and Inclose implants are now commercially available for annuloplasty and can be
seen as modified sutures with anchors.9,11
The Inclose Surgical Mesh System received FDA 510(k) clearance on August 18,
2005. The surgical mesh is comprised of polyethylene terephthalate (PET) monofilament

19

expandable braided material that is preloaded on a disposable delivery tool inserted through
the defect of the tissue, and affixed to surrounding soft tissue with the anchor bands (nonabsorbable sutures). It is proposed as an alternative procedure for annular repair, following
a discectomy, to re-approximate the compromised tissue of the AF.
These devices however do not address the underlying issue of using sutures to close
the AF. Also, sutures and these devices are fully directed to the containment of the NP, but
they do not compensate for the loss of annulus material nor reverse the biomechanical
changes that have occurred in the damaged AF.
The Barricaid Device received the CE Mark approval for marketing in Europe in
April 2009. It has thus far yet to receive FDA 510(k) clearance for marketing in the U.S.
The Barricaid consists of a polytetrafluoroethylene (ePTFE) woven mesh supported by a
titanium bone anchor. The function of the device is to form a mechanical barrier that closes
the annular defect. The device is intended for use in individuals with primary IVDH with
large annular defects. It is a commercially available implant used in adjunction to
discectomies that fully bridges the defect in the AF.12 According to the manufacturers’
website, “the Barricaid enables surgeons to directly reconstruct the annulus in the region
of the herniation.”
The DART System received CE Mark approval for marketing in Europe in April
2009. It has yet to receive FDA 510(k) clearance for marketing in the U.S. The device
consists of a polyetheretherketone (PEEK) implant that provides closure of the AF. When
implanted, it is placed near the central axis of rotation along the posterior edge of the
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vertebral body. It is secured in place by the apophyseal ring along the vertebral body load
column.
DEVELOPING SCAFFOLDS FOR ANNULUS FIBROSUS TISSUE
ENGINEERING
Ideal AF devices used for tissue engineering is to achieve both immediate
mechanical stability and to allow regeneration of native tissue over time. Currently, there
is a missing link between addressing AF closure techniques and regenerative strategies.
Closure techniques primarily focus on restoration of the mechanical integrity of the AF,
while regenerative therapies target the engineering of healthy and functional AF tissue.
Furthermore, closure techniques offer the clear implantation and fixation strategy;
however, regenerative therapies lack the strategies for implantation and fixation that limits
their clinical application.71
To develop a suitable scaffold for tissue engineering, certain general principles
have to be addressed including, biocompatibility, biodegradability, and method of
delivery.116 On the microscale specific requirements for AF scaffolds include: fill and/or
repair the AF defect to contain the NP, allow fixation to the surrounding structures (i.e.
endplates and/or surrounding AF tissue), allow AF cells (AFCs) (or stem cells) to survive
(differentiate/proliferate), synthesize and secrete the native ECM, have the characteristic
anisotropic behavior to maintain/restore the mechanical properties of a spinal motion
segment, and not irritate or adhere to the perineurium of the spinal cord.71 Table 3
highlights the difficulties and challenges in tissue engineering seen within the cells,
scaffolds, anatomy, and physiology.
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Table 3: Difficulties and Challenges in Tissue Engineering of the AF Reported by
Sharifi et. al.3



Sources of Cells











Tissue-Engineering
Scaffolds



Anatomy and
Physiology









Limited Sources of human cells due to the unavailability of
healthy tissue
Biopsies taken from healthy AF do not contain sufficient
cells
Risk of damage to AF during biopsy
Difficulty distinguishing inner and outer AFCs
Difficulties in cell culturing. Loss of cell phenotype in 2D
cell culture and the requirement for specific media and
culture conditions
Lack of suitable cell markers for AFCs
Poor survival of transplanted cells
Requirement of anisotropic physical and mechanical
characteristics mimicking the healthy AF
Requirements change with extent of IVD degeneration
Limited integration with native AF tissue
Confirmation to the site of implantation that hinders
implantation and restricts implant geometry
Provides an aqueous medium for cell survival, while
simultaneously maintaining mechanical properties
Need to promote cell attachment and provide signals for
normal cellular activity in the AF ECM
Wish for radio-opacity to allow medical follow-up
Method of surgical implantation or injection
Avascularity of the tissue
Limited nutrient transport and waste disposal
Low healing potential
Low cell numbers
Lack of an animal model of the human degenerated IVD

Overall formation of a scaffold is summarized into two classifications: single
composition (oriented or non-oriented to mimic the organized native lamellae) or gradient
composition to simulate internal and external layers of the AF. A gradient structure would
have an external layer enriched in collagen type I, and an internal layer comprised of more
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collagen type II to mimic the native structure of the AF. Several other novel suture, seal,
and barrier techniques are currently being developed, resulting in an increasing attention
at scientific workshops and conferences.8–15
POTENTIAL CELL SOURCES FOR ANNULUS FIBROSUS SCAFFOLDS
In current research, as seen in Table 4, the cells used in conjunction with the
mechanical scaffolds include both stem cells and native AFCs.117–124 Within the native
human AF, mature subjects have a cell density of ~9*106 cells/cm3, which is two times
greater than the NP.125 A recent study showed that cells derived from the human AF were
able to differentiate into the chondrogenic and adipogenic lineages.126 This suggests that
cells in the AF could be skeletal progenitor cells that could be recruited under pathologic
conditions such as herniation. Otherwise, progenitor cells from surrounding tissue might
perhaps be capable of migrating into the IVD.71 However, isolation of the cells retrieved
from a human discectomy procedure typically does not allow for division between internal
and external AFCs.
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Table 4: Cell Types Used for AF Repair in Current Research for AF Repair

Type of Cells
Porcine Annulus Fibrosus Cells
Mesenchymal Stromal Cells (MSCs)
Human Annulus Fibrosus Cells
Bovine Annulus Fibrosus Cells
Porcine chondrocytes
Rabbit Bone Marrow-Derived MSCs (BMSCs)
Rabbit Chondrocytes
Bovine Annulus Fibrosus Cells
Rat Annulus Fibrosus Cells
Ovine Annulus Fibrosus and Nucleus Pulposus Cells
Murine Annulus Fibrosus Cells
Canine Annulus Fibrosus Cells

INVESTIGATED SCAFFOLD DEVELOPMENT
Abundant varieties of scaffolds have been investigated for AF tissue engineering in
academic laboratories. With tissue engineering being a new scope of study and associated
high development costs, AF scaffolds are being developed mostly in the academic field.
Researchers continue to try and create a suitable AF replacement. Table 5 lists current
materials being used with the hope of mimicking either the native AF structure and/or
function.
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Table 5: List of Scaffolds Investigated for AF Repair

Type of Scaffolds
Biodegradable Glue (HDI-TMC1-PEG200-TMC1-HDI tissue glue)
Alginate-based collagen shape-memory composite scaffolds
Poly(trimethylene carbonate) (PTMC) scaffolds with an elastic poly(ester-urethane)
(PU) membrane
Electrospun biologic laminates
Biodegradable shape-memory polymer network prepared by photo-crosslinking
poly(D,L-lactide-CO-trimethylene carbonate) dimethacrylate macromers
Expandable scaffold-free neoconstruct
Bioactive poly(L-lactide) (PLLA/TGF) electrospun scaffold
Biphasic whole IVD using silk protein for the AF and fibrin/hyaluronic acid gel for the
NP
Biphasic IVD by electrospinning using PCL as the AF and agarose as the NP
Biphasic whole IVD using collagen 1 for the AF and alginate for the NP
Bone marrow-derived MSC sheets and silk scaffolds
Biphasic scaffold using demineralized bone matrix gelation (BMG) as the AF and
elastic material based on poly(polycaprolactone triol malate) (PPCLM) as the NP
Porous silk scaffolds
PDLLA (poly(D-L-lactide)/Bioglass composite foam scaffold
Alginate/chitosan hybrid fiber scaffold
Oriented electrospun nanofibrosus scaffolds
Biodegradable poly(1,8 octanediol malate) (POM) scaffold
Polyglycolic acid (PGA) and calcium alginate mesh coated with 1.5% w/v polylactid
acid
Atelocollagen honeycomb-shaped scaffold with a membrane seal (ACHMS-scaffold)

In 2015, Vergroesen et al. published a research study on a biodegradable glue for
annulus closure. The aim of the study was to investigate the feasibility and biomechanical
properties of biodegradable glue for AF repair, using non-degenerated caprine IVDs. The
glue consisted of a biodegradable HDI-TMC1-PEG200-TMC1-HDI tissue glue. The
ultimate strength and endurance tests were performed using native and punctured IVDs as
positive vs. negative controls. Results demonstrated that the biodegradable glue was able
to provide a reduction in the risk of herniation; however, the majority of the IVDs (n=9/11)
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failed by nucleus protrusion. Before protrusion of the AF occurred the glue demonstrated
a trend toward the partial restoration of the native AF ultimate strength. Results of the study
showed: 1) the glue partially restores annulus integrity after a puncture, 2) increases the
amount of force required to cause nucleus protrusion through the AF puncture occurs, and
3) limits the number of herniation’s during ambulatory loading and ultimate strength tests.
The use of biodegradable glue for AF repair provides a low-cost method, but the efficacy
would need to be evaluated in long-term studies.127
In 2015, Guillaume et al. published a research study on enhancing AF cell migration
in shape-memory alginate collagen composite scaffolds through in vitro and ex vivo
assessment for IVD repair. For this study, collagen was incorporated into alginate-based
shape-memory scaffolds. Addressed were the advantages of using alginate or collagen
independently, in producing mechanical stability, injectability, and biological activity. In
vitro studies demonstrated that performed alginate scaffolds promoted AF cell penetration
and preserved the natural cell phenotype. Also, porcine AF and MSC-seeded scaffolds,
with the incorporation of collagen, showed to have a beneficial effect on cell proliferation
and ECM deposition. The matrix secretion was amplified by the local release of TGF-β3
growth factor compared to those of non-supplemented media. During ex vivo experiments,
collagen-enriched scaffolds maintained MSC viability and allowed for attachment of
endogenous AFCs from the surrounding tissue and showed infiltration into the 3D
constructs compared to alginate only scaffolds.128
In 2014, Sharifi et al. published a research study on the treatment of the degenerated
IVD through closure, repair, and regeneration of the AF. With cell-based therapies to
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regenerate degenerated IVDs, mesenchymal stromal cells (MSCs) are more readily
available in contrast to differentiated autologous or allogenic cells. One of the difficulties
in cell therapy is most transplanted cells will not survive the ischemic conditions
immediately after implantation. It was previously demonstrated with transplanted MSCs,
80-90% died within five days after implantation in an osteochondral defect via rabbits, thus
using MSCs for IVD treatment seems imprudent.129 Further addressed were the advantages
and disadvantages of cell types for direct transplantation into the degenerated IVD.
Autologous NP or AFCs do not initiate an immune response, although they are not
available in sufficient amounts, and healthy state, their phenotype change upon expansion
in monolayer culture, and additional surgery is required to obtain NP or AFCs with the risk
of causing further IVDD upon harvesting. Allogeneic NP or AFCs do not initiate an
immune response, and healthy cells are available; although, there is a limited availability
of allogenic human NP or AFCs, and there is a risk of IVDD upon harvesting. Autologous
stem cells elicit no immune response and are available in sufficient amounts; however,
there presents a lack of definitive phenotype markers for NP or AFCs. Allogenic stem cells
do not elicit an immune response and have “off the shelf” availability; although, they also
lack definitive phenotype markers for NP or AFCs. Lastly, chondrocytes are available in
sufficient amounts, but they have a different phenotype compared to NP or AFCs.3
In 2014, Pirvu, et al. published a study that included a combined biomaterial and
cellular approach for AF rupture repair. The study utilized poly(trimethylene carbonate)
(PTMC) scaffolds seeded with bone marrow-derived MSCs in a combination with an
elastic poly(ester-urethane) (PU) membrane. The mechanical properties of the PU
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membrane showed an ultimate strength of 53.0 +/- 2.0 MPa, and a yield strength of 4.9 +/1.4 MPa. The surfaces and cross section showed the absence of large pores and minor
amounts of non-connected micro-porosity. Through testing it was demonstrated the PTMC
implant combined with the sutured PU membrane restored IVD height of annulotomized
IVDs, and prevented herniation of NP tissue into the AF defect. In comparison, press-fitted
implants without closure were not able to withstand dynamic loading and were pressed out
of the defect immediately after starting loading cycles. The PU membrane sutured onto the
AF tissue was used to cover the scaffold and seal the defect. After 14 days of repetitive
dynamic load, the sutured PU membrane retained the PTMC scaffold within the AF defect,
and no herniation of the NP was observed. Through cellular studies, MSCs showed
potential of positively modulating cell phenotype of native IVD tissue by up-regulating
anabolic mechanisms and downregulating catabolic mechanisms in host IVD cells. MSCs
were implanted into the AF defect by first embedding in fibrin hydrogel. After 14 days of
culture, in situ, with repetitive dynamic load, the implanted MSCs remained within the
PTMC scaffolds. This suggests that implanted MSCs can adapt their phenotype during
culture within IVDs.130
In 2013, Guillaume et al. published a research study on shape-memory porous
alginate scaffolds for regeneration of the annulus fibrosus and the effect of TGF-β3
supplementation and oxygen culture conditions. The porous shape-memory alginate
scaffolds were structurally based on covalently cross-linked alginate. Manual manipulation
of the scaffolds exhibited shape-memory capability suitable for delivery in AF defects of
the IVD through minimally invasive approaches. The scaffold was developed as a support
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template for AF cell proliferation and tissue formation. In vitro testing demonstrated
cytocompatibility when seeded with porcine AFCs and supported cell penetration,
proliferation, and ECM deposition when cultured in IVD like micro-environmental
conditions (low oxygen and low glucose concentrations) with TGF- β3 media
supplementation. With TGF- β3, after three weeks of culture sulphated GAG (sGAG) and
collagen type I were detected throughout the entire porous network of the alginate scaffold.
Without TGF-β3, cells agglomerated in small clusters with limited proliferation which
resulted in poor ECM deposition. It was also stated that cells did not appear to attach
directly to the alginate structure itself. Guillaume believed this to be due to the low cell
adhesion properties of alginate, and to mimic the natural orientation of collagen fibers in
engineering scaffolds, various fabrication methods and specific architectures have been
investigated previously. These structures could potentially be incorporated into the alginate
solution before cross-linking to create a composite alginate-based porous scaffold with
aligned fibers.131
In 2013, Driscoll et al. published a research study on biaxial mechanics, and interlamellar shearing of stem cell seeded electrospun angle-ply laminates for AF tissue
engineering. The study focused on electrospun biologic laminates reaching biaxial
properties of the native tissue. It was found that properties of the opposing (± 30°)
constructs were significantly higher than the aligned constructs despite showing similar
fiber stretch ratios. This could indicate that a lamellar structure with native tissue fiber
orientation can provide higher stiffness than a single aligned fiber population, due to biaxial
boundary conditions. It is stated that the use of biaxial testing is necessary for an
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appreciation of this difference since previous uniaxial tensile testing showed single
lamellar 0° constructs to be about twice as stiff as opposing constructs. This provides
further evidence that a lamellar structure with two alternating or angle-ply fiber populations
is an important design criterion for both native tissue and a mechanically functional
engineered AF. The limitation of the electrospun angle-ply laminates was found to be the
strain levels. Native AF function under large strains without failing and typical have highly
nonlinear mechanics with large toe regions. The electrospun biologic laminates displayed
a nonlinear response to strain, although at a lesser extent and with a smaller toe region than
the native tissue.132
In 2013, Sharifi et. al. published a research study on an AF closure device based on
a biodegradable shape-memory polymer network. The biodegradable elastic polymer
network was prepared by photo-crosslinking poly(D,L-lactide-CO-trimethylene carbonate)
dimethacrylate macromers. The mechanical properties of the scaffold were reported in the
range of native human AF tissue for tensile strength, elastic modulus, and elongation at
break. The cell culture of human AFCs (HAFCs) showed good cell adhesion and
proliferation. Cell culturing studies were evaluated on network specimens that were either
pre-coated or not-coated with fibronectin. Fibronectin was utilized because it is previously
reported as an ECM protein that improves cellular adhesion on a polymer surface. The
feasibility of the shape-memory device was evaluated using a cadaveric canine model.
Upon insertion into the IVD, the device had begun to deploy. It was reported that the
network samples had a shape-recovery rate of 9.3% per minute when heated at a rate of 2°
C per min. After overnight incubation at 37° C, the IVD was cross-sectioned. It was found
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that the implant recovery to its permanent shape was not complete. This was believed to
be due to the shape-recovery force of 1 MPa not being larger than the force exerted by the
surrounding AF tissue on the implant. Also, through manually applied flexion and
extension forces, and axial rotations the implants dislodged from their original positions.
Thus, it is necessary for an improvement in the design of the implant to increase the
mechanical properties needed to withstand native forces.133
In 2013, Cho et al. published a research study on the construction of a tissueengineered AF. In this study, they characterized an expandable scaffold-free neoconstruct
using autologous AFCs. The construct was prepared from pellet cultures, derived from
monolayer cultures of AFCs from mature pigs, until the cells had reestablished a
proteoglycan rich cell associated matrix. The second step consisted of the removal of the
cells embedded in their own ECM products as a membrane from culture plates and
subsequent maintenance as a detached explant tissue. This method consisted of using only
the matrix produced by the cells themselves and does not require the use of exogenous
matrices. The collagen content and biomechanical properties after three weeks of culturing
was similar to that found in mature porcine AF tissue. The principle advantages of these
constructs observed were the artificial materials are not required to obtain a sizable 3D AF
tissue construct, and the cell distribution was uniform. This contrast could provide
applications for analysis of cell behavior as it provides a well-defined 3D environment for
studies of biomechanical load or growth-factor stimulation.134
In 2012, Vadala et al. published a research study on bioactive electrospun scaffolds
for AF repair and regeneration. The scaffold was synthesized by electrospinning, with a
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direct incorporation of TGF-β1 into the polymeric solution. The scaffold was a poly(Llactide) (PLLA/TGF) electrospun scaffold. The electrospun scaffold consisted of a nonwoven porous mesh with randomly oriented fibers. The study demonstrated a sustained
release of growth factors and inducement of anabolic stimulus on bovine AFCs while
mimicking the ECM three-dimensional environment of the AF tissue.135
In 2012, Chan et al. published a research study on IVD regeneration or repair with
biomaterials and stem cell therapy, and if it is feasible or fiction. They describe how
commercially available implants for closing the AF reinforces the complete posterior
annulus and could prevent contralateral herniation. Although, these devices are unable to
maintain the biological AF structure in the long-term or stop AF degeneration. Tissue
engineering methods aim to close the injured AF to prevent IVDH as well as to stop the
AF from further degeneration. They also identified the previously attempted engineering
approaches, such as hydrogels, alginate, PDLLA/Bioglass, silk, and electrospinning
discussed further in this paper. Additionally, a whole IVD tissue engineered total disc
replacement was addressed: A biphasic whole IVD using silk protein for the AF and
fibrin/hyaluronic acid gel for the NP using porcine AFCs and chondrocytes respectively.
Another approach described was a fabricated biphasic IVD by electrospinning using PCL
as the AF and agarose as the NP. Lastly, the last approach addressed was a biphasic whole
IVD using collagen 1 for the AF and alginate for the NP. An issue they address is the major
challenge of not de-differentiating cells in culture after in vitro culture. With primary cells
starting to dedifferentiate when they are cultured in vitro over long passaging (p>6),
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strategies are needed to control the state of the cells to ensure these cells are not dedifferentiated over long expansion time and remain suitable for IVD tissue engineering.136
In 2012, See et al. published a research study on simulated IVD-like assembly using
bone marrow-derived MSC sheets and silk scaffolds for AF regeneration. The structure
used to form the IVD-like assembly was constructed of a cylindrical silicone NP substitute.
The study addressed the potential to regenerate the AF by using rabbit bone marrowderived MSCs (BMSCs) to form cell sheets and incorporating them onto silk scaffolds.
The study demonstrated that BMSC cell sheets can be successfully transplanted and adhere
well when combined with silk scaffolds. The cells within the assembly remained viable
and showed the presence of GAGs throughout the ECM. Through immunohistochemical
(IHC) staining, collagen type I and II were present and the composition of type II increased
from 8% to 70% over a four week culture. This could prove this method has potential to
regenerate ECM similar to that of the internal AF. One shortfall of the study was no specific
markers or genes to are known to differentiate the IVD cells from other lineage-specific
cells. However, due to the lack of specific markers, studies have only reported that the
internal and external AF have a gene expression profile and ECM that resembles those
synthesized by articular chondrocytes and fibroblasts, respectively.137
In 2008, Wan et al. published a research study on a biphasic scaffold for AF tissue
regeneration. In this study, a biphasic scaffold was used to simulate the annulus both
structurally and elastically. They describe the generation of a cylindrically shaped
composite implant designed to emulate the AF. The outer phase of the scaffold consisted
of demineralized bone matrix gelation (BMG). The inner phase of the scaffold was
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constructed of an elastic material based on poly(polycaprolactone triol malate) (PPCLM).
The BMG phase was used to increase the mechanical strength and to simulate the
ligamentous structure of the outer AF. The PPCLM phase was seeded with rabbit
chondrocytes that showed proliferation and ability to maintain their phenotype with a four
week culture.123
In 2008, Chang et al. published a research study on enhancing AF tissue formation
in porous silk scaffolds. This study was an extension to their previous publication, “Porous
Silk Scaffolds to be used for Tissue Engineering.” The aim of this study was to determine
whether dynamic culture and/or scaffold pore size would influence AF tissue formation
and distribution in silk scaffolds in vitro. It was shown that scaffolds with an average 600
μm pore size appeared to be the best model to mimic the native AF. Scaffolds were seeded
and grown in either static culture or spinner flasks (90 rpm). After two weeks, scaffolds in
the dynamic culture showed greater than 3-fold increases in collagen accumulation per cell
compared to static cultures, and a 1.5-fold increase per cell in proteoglycan accumulation.
The tissue generated under dynamic conditions also appeared to be more cellular as the
DNA content was significantly greater compared to static cultures. However, in both the
static culture and spinner flasks the scaffolds had a similar pattern of tissue distribution as
more tissue was present on the outer surface, with little tissue formation on the interior of
the scaffold.138
In 2008, Helen et al. published a research study on cell viability, proliferation, and
ECM production of HAFCs cultured within PDLLA/Bioglass composite foam scaffold in
vitro. The scaffolds were comprised of poly(D, L-lactide) (PDLLA)/Bioglass. The PDLLA
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composite foams were combined with varying percentages (0, 5, and 30 wt.%) of Bioglass
through thermally induced phase separation (TIPS), and characterized by scanning electron
microscopy (SEM). HAFCs were used to determine viability, cell attachment,
proliferation, and proteoglycan/collagen production. Live/dead staining showed viable
HAFCs were present on the top surface of the foams as well as penetrating into the internal
pore structure. SEM observations revealed larger quantities of clusters of HAFCs were
attached to the pore walls to the foams with 5 and 30 wt.% Bioglass in comparison to the
0 wt.% Bioglass. DMMB assays showed HAFCs cultured within the PDLLA/30BG foam
had a greater ability to deposit collagen and proteoglycan after four weeks of culture
compared to lower wt.% Bioglass. IHC analysis of collagen production demonstrated that
collagen produced in all cultures was predominantly type I collagen, similar to collagen
found in the external AF.122
In 2007, Chang et al. published a research study on porous silk scaffolds to be used
for tissue engineering. The biomaterial used was a protein polymer made by silkworms,
silk fibroin. The idea that the use of a silk scaffold would potentially degrade at a
sufficiently slow rate would allow for proper tissue development, and could be covalently
coupled to peptides to allow for the potential of enhancing cell attachment. The results of
the study demonstrated that AFCs adhered to porous silk scaffolds and synthesized
collagen and proteoglycans after attachment: with a 10-fold increase in collagen deposition
and a small increase in proteoglycan content. After 24 hours, 35% cells seeded into the
scaffold had attached, but only a significant increase in cellularity was observed on day 56.
However, with the coupling of RGD-peptides, there was no evidence of further cell
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attachment, collagen accumulation, or tissue formation. RGD decoration showed to have
no effect on cell seeding efficiency or morphology. The silk fibroin scaffold was found to
be a suitable scaffold material for AF tissue engineering; however, it was observed that
tissue growth was limited and not uniformly distributed throughout the scaffold.118
In 2007, Shao et al. published a research study on developing an alginate/chitosan
hybrid fiber scaffold for AFCs. The study utilized a fibrous scaffold made of alginate or
alginate/chitosan created by wet-spinning and lyophilization. Demonstrated through
testing, alginate/chitosan hybrid scaffolds exhibited a slower degradation rate than pure
alginate fiber scaffolds while both scaffold types did not display any cytotoxicity to 3T3
fibroblasts and could maintain canine AFC growth. Cellular studies showed AFCs retained
their spherical shape within the fibrous scaffold at the beginning of the culture period and
formed into cell aggregates at later time points. ECM molecules, including collagen I and
II, aggrecan deposition were also detected in the AFC clusters.117
In 2007, Nerurkar et al. published a research study on the mechanics of oriented
electrospun nanofibrous scaffolds for AF tissue engineering. The study utilized electrospun
poly-ε-caprolactone nanofibrous polymer scaffolds. Bovine AFCs were seeded onto the
scaffolds, and biochemical analysis was performed on days 1, 14, 28. The model was used
in contrast against single lamellae of the native internal and external regions of the AF.
Results demonstrated elongated cells aligned along the predominant fibers direction with
proteoglycan (s-GAG) and collagen content increase over the four week culture. Uniaxial
tension mechanical testing was performed on various fiber angles of the scaffold: 0°, 15°,
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30°, 45°, and 90°, and showed that moduli varied nonlinearly between the different fiber
angles. A nonlinear decrease in modulus was seen with increasing fiber angles.120
In 2007, Wan et al. published a research study on a novel biodegradable poly(1,8
octanediol malate) for AF regeneration. The scaffold was formed using malic acid-based
polyester poly(1,8 octanediol malate) (POM), which was synthesized by direct
polycondensation. Tensile strength, compressive stress, and compressive Young’s
modulus of POM demonstrated an increase with the extension of the polymerization time
of POM. However, degradation rates and elongations of POM decreased with extensive
polymerization of POM. Rat AFCs were seeded onto the scaffold and showed that AFCs
did not attach readily to the polymer after polymerization times less than two days. Rat
AFCs were then cultured in monolayers for 1, 2, and 4 days. As time points increased,
proliferation of cells with stellate and elongated morphology was seen, with an increase in
gene expression for aggrecan and type II collagen only seen on day 4.121
In 2007, Wan et al. published a research study on a biphasic scaffold for AF tissue
regeneration. They created a biphasic elastic scaffold comprised of an inner and outer phase
sections. The outer phase was a ring-shaped demineralized BMG extracted from cortical
bone. The BMG was studied due to its ECM composition of mainly type I collagen, its
natural biomechanical properties, and because it contains insoluble bone morphogenetic
proteins, non-collagenous proteins, and intrinsic growth factors. The inner phase was a biobiomaterial poly(polycaprolactone triol malate) (PPCLM) orientated in concentric sheets
and seeded with chondrocytes. Mechanical testing was conducted on the scaffold to test
for the incorporation of BGM into the PPCLM scaffold. Through testing, it was found that
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mechanical properties and degradation of PPCLM could be adjusted by controlling the
post-polymerization time of the pre-polymer. Mechanical testing results demonstrated
good biocompatibility in foreign body response in vivo assay, enhanced compressive
strength and 50-fold greater tensile stress. Rabbit chondrocytes were seeded onto the
scaffold and showed proliferation and penetration into the inner phase after four weeks.
Production of type II collagen and aggrecan was detected in both phases of the scaffold.123
In 2006, Helen et al. published a research study on the potential use of
PDLLA/45S5 (PDLLA-poly(D-L-lactide))/Bioglass composite films for the culture of
AFCs in vitro. The study evaluated the attachment and matrix production of bovine AFCs
to four different substrates. They chose to combine bioactive glass with degradable
polymers due to the ion dissolution products of the bioactive ceramic counteract the acidic
degradation products of the polymer to reduce the inflammatory response. Through SEM
analysis it was shown that cells had attached and spread on all films after three days and
had proliferated to form a confluent monolayer of cells by day 7. sGAG production was
measured, and shown that PDLLA/30BG had enhanced sGAG production after three
weeks; although, after four weeks in cultures sGAG production decreased. The results of
the study showed that PDLLA/Bioglass provided an appropriate substrate for AFCs and
that these films promote the production of an ECM containing abundant sGAG and
collagenous proteins.139
In 2004, Mizuno et al. published a research study on tissue-engineered composites
of the AF and NP for IVD replacement. The study used a polyglycolic acid (PGA) and
calcium alginate mesh coated with 1.5% w/v polylactic acid solution. AF and NP ovine
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cells were seeded onto PGA and alginate scaffolds to create a tissue with AF and NP
components. Based on histologic and biochemical characteristics of the tissue-engineered
IVDs, they presented similar to those of native IVDs based on morphology and quantities
of collagen and proteoglycans produced. DNA content remained constant during first eight
weeks but increased greatly between 12-16 weeks in vivo. Amounts of hydroxyproline and
GAG increased with time with GAG reaching native tissue levels after 16 weeks.119
In 2002 and 2003, Sato et al. published research studies on an atelocollagen
honeycomb-shaped scaffold with a membrane seal (ACHMS-scaffold) and the
regeneration of the IVD with an allograft of cultured AFCs. During manufacturing, it was
found the diameter of the pores could be controlled by changing the concentration of
collagen solution and ammonia gas. The first study demonstrated stability,
cytocompatibility, uniform seeding of cells, and accumulation of produced matrix
components within the ACHMS-scaffold. The objective of the second study was to
investigate the regeneration of IVDs after laser discectomy using their tissue engineering
methods. They used AFCs isolated from Japanese white rabbits and seeded them onto the
ACHMS-scaffold for one week. They then implanted the scaffold into the lacunas of an
IVDs of recipient rabbits that had the NP vaporized by a laser. Results demonstrated cells
proliferated and retained spherical shape, higher increases in type II collagen and GAG
content than compared to monolayer content, and a presence of accumulation of cartilagelike matrix after insertion.124,140
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TISSUE ENGINEERING AND REGENERATIVE MEDICINE
Tissue engineering evolved from the field of biomaterials and refers to the
combination of scaffolds, cells, and suitable biochemical and physicochemical factors to
form functional tissues to improve/replace biological functions. There is a need to create
an effective AF repair device with could improve patient outcomes and reduce healthcare
costs while preventing re-herniation and the need for spinal fusion for patients with IVDH
and IVDD, respectively. Regeneration of the damaged AF is an appealing concept since it
permits restoration of all functions of the AF; however, this concept is exceptionally
complex to attain. It must be able to endure the direct mechanical strength applied and be
a size sustainable to contain the NP.141 The progression in development needed for the
success of regenerative strategies of the AF consists of three major components: cell
therapy, gene therapy, and scaffolds.63 Proclaimed in a recent study, the ideal strategy for
IVD regeneration is to restore the function and integrity of the IVD by using biomaterials,
native matrices, growth factors, and cells that produce matrices; although, with the complex
biological, mechanical environment of the IVD makes the synthesis of an artificial IVD a
difficult task.85 However, while a difficult task, without a functional AF repair device to
resist expulsion of NP tissue and the IDP, generated within, IVD regeneration and
prevention of IVDD and IVDH is deemed to fail.
During the early 2000’s there was an increase in research of NP replacements with
the goal of restoration of the physiological IDP and IVD disc height. However, there was
a lack of effective strategies that combated the damaged AF (incurred via implantation of
such devices or the pathological processes). Current strategies for NP replacements attempt
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to restore native NP mechanical properties, but do not address the issue of the inferior
quality of the surrounding AF, which is not capable of withstanding IDP.71 Recently in
research, IVD engineering strategies are increasingly focusing on the regeneration or repair
of the AF in order to reduce the number of re-herniation’s, increase the potential of NP
engineering strategies, and to mechanically assist NP replacement therapies.141,142
An effective AF closure/repair device in conjunction with a less aggressive
discectomy for IVDH and/or NP arthroplasty for IVDD, may result in improving patient
outcomes, decreased pain, and provide fewer revision surgeries via lower re-herniation and
expulsion rates.5,6 In either case, an intact AF must be re-established to prevent implant
expulsion or re-herniation, thus addressing the two major spinal pathologies directly
associated with an IVD. Therefore, it would be advantageous to develop a biomimetic
patch for biological augment AF repair to help mitigate this re-herniation.
The objectives of this research were to investigate the development of a biomimetic
patch for biological augment AF repair through: (1) characterizing the micro-architecture
of the multi-laminate angle-ply AF patch, (2) evaluating the mechanical properties of the
developed multi-laminate angle-ply AF patch, and (3) evaluating the cytocompatibility of
the multi-laminate angle-ply AF patch.
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CHAPTER II
MATERIALS & METHODS

SPECIMEN PROCUREMENT, DISSECTION, AND TREATMENT
Porcine hearts were obtained at time of slaughter from a local abattoir. The parietal
layer of the pericardium was separated from the heart, and excess adipose fatty tissue and
connective tissue were removed by manual separation using tweezers and scalpel blades.
The parietal pericardium layer was chosen due to its natural structure. The parietal
pericardium is fused to and inseparable from the fibrous pericardium (most superficial
layer of the pericardium). It consists of dense and loose connective tissue containing
collagen type I.143 The dense connective tissue is divided into regular and irregular sections.
Dense regular connective tissue contains collagen fibers bundled in a linear/parallel
orientation. The presence of these collagen fibers were utilized during fabrication of the
scaffold. The decellularization procedure was adapted and modified from methods
described by Teeder et al without elastase treatment.144
FABRICATION OF BIOLOGICAL COLLAGEN ANGLE-PLY SCAFFOLD
Multi-laminar angle-ply collagen patches were designed to mimic the native
architecture of the AF. Angle-ply patches consisted of multiple layers of pericardium tissue
adhered together via a sewing machine, backing material, and suture thread (Rachel
Reference if previously reported). Single layers of pericardium were placed on a light box
to determine the preferred direction of the collagen fibers. The layers were then stacked
one on top of the other at ± 30° alternations to create the native angle-ply formation
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(Figure 7). For sewing, the layers were placed on top of a water-soluble backing material
(solvy-ultra). The backing tissue was necessary during sewing to provide even positioning,
and to permit the needle to puncture all the layers of the pericardium. Dimensions of 8 x 8
mm2 were sewn into the layers to create the multi-laminar angle-ply patch. The backing
material was then removed manually by hand/tweezers, and stored in ddH2O for 4 hours to
ensure complete degradation from the patch. The dimensions of a three layer patch are:
length (8 mm), height (8 mm), and width/thickness (0.8 mm).
ISOLATION AND EXPANSION OF BOVINE AF CELLS
Three bovine tails from young calves were obtained at time of slaughter from a
local abattoir. The caudal discs were separated using mechanical shears, and the NP was
removed first through a 6mm biopsy punch in order to ensure harvest of only the AF. The
AF tissue was then removed and minced using two scalpel blades. The tissue was then
transferred to a 50 ml conical tube with 25 ml of collagenase solution (1% Ab/Am, 0.2%
Collagenase Type I (125 units/mg dry weight) and DMEM). Following tissue digestion
overnight (~18 hours) at 37°C, the solution was centrifuged at 1000 rpms for 5 minutes.
The supernatant was removed and the cells were re-suspended in cell culture media (1%
Ab/Am, 10% FBS and DMEM). Passage 2 (P2) bovine AF cells were used in the current
study.
CELLULAR ANALYSIS
Cellular studies were conducted on the multi-laminar angle-ply AF patch to ensure
cell viability on all layers of the patch. Previous laboratory testing showed that bovine
AFCs were viable on the surfaces of the patches through day 15 studies; however, cell
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viability between the upper and lower layers was unattainable. Multiple variations of tissue
disruption modifications were used with the hypothesis of degrading the tissue matrix to
provide more nutrients to the inner layers. For all studies, patches were prepared by resterilization and neutralization before cell seeding. Sterilization occurred by placing the
patches in a specimen cup with 100 ml of 0.1% Peracetic Acid on a shaker at room
temperature for two hours with a speed of 150 rpms. The patches were then washed in 100
ml of sterile PBS for 1 hour (3x) on a shaker at room temperature for one hour with a speed
of 150 rpms. The patches were then neutralized in 100 ml of sterile 50% fetal bovine serum
(FBS)/ 48 % Dulbecco’s Modified Eagle Medium (DMEM) + 2% antibiotic/antimitotic
(Ab/Am) overnight on a shaker at room temperature with a speed of 150 rpms. The tissue
disruption performed and discussed herein was sonication of the tissue. Pericardium tissue
was placed in a Sonicator for 20 minutes prior to patch fabrication. Sonication affected the
tissue by pressure created through a probe which rapidly expands and contracts at high
frequencies. The high frequency oscillation is due to the piezoelectric effect, with rapid
oscillation of the current causing tiny shock waves.145
AF CELL SEEDING ONTO SCAFFOLD
Following sterilization and neutralization, patches were divided into 2 separate
groups: control and sonicated. 5 x 106 cultured bovine AF cells at passage 2 (P2) were
placed in a predetermined amount of cell culture media. Previous studies not shown herein,
determined the optimized volume amount to prevent run-off of the patch. 6 x 105 cells were
seeded per patch (16 x 103 cells per mm2): 2 x 105 cells were seeded in 40 μl of CCM onto
the top the patches, 2 x 105 cells seeded in 75 μl of CCM were injected into the middle
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layers using an 18 gauge needle. The patches were then incubated at 37°C for four hours
for cell attachment. After incubation, the patches were flipped using sterile tweezers, and
the same process was completed for seeding 2 x 105 cells in 40 µl of CCM onto the bottom
of the patch.
STAINING HISTOLOGY
Representative samples of single layer decellularized pericardium were aligned in
alternating degrees to illustrate the articulation of the alternation of fibers within
pericardium tissue. This was performed with the intent to mimic the native angle-ply
foundation of the human AF. Patches were fabricated as stated above, in ± 30° and + 30°
alternations. The samples were then analyzed via histological analysis. Representative
samples were placed in histological cassettes with gauze to hold the sample in place and to
prevent swelling between the layers. The samples were then fixed in neutral buffered
formalin for 24 hours, embedded with paraffin wax, and sectioned at 5 μm thickness.
Hematoxylin and Eosin (H&E) staining was performed to visualize cellular material and
tissue extracellular matrix. Masson’s trichrome staining was used to define the composition
of the pericardium tissue, and to verify the angle-ply alternation between the layers. A Zeiss
Axio Vert.A1 camera microscope with AxioVision SE64 Rel. 4.9.1 software was using for
imaging and reviewing of the histological slides.
BIOMECHANICAL EVALUATION OF MULTI-LAMINATE AF PATCH
ULTIMATE TENSILE STRENGTH
Mechanical tensile testing was performed on decellularized single and multilaminar angle-ply AF patches to ensure comparable tensile ultimate tensile strength (UTS)
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to native human AF tissue. This is deemed crucial to ensure the patch does not disrupt the
function of the native tissue, and is able to withstand the max tensional force experienced
during extension and flexion. The representative samples for the decellularized single layer
pericardium were tested in a fiber preferred (tension applied parallel to collagen fibers;
n=5) and cross-fiber direction (tension applied perpendicular to collagen fibers; n=5).
Representative samples of three layered multi-laminar angle-ply AF patches were also
tested (tension applied at ± 30° alternating angles of patch aligned to the vertical axis;
n=5). The tensile testing protocol was adapted from methods describing single human AF
lamellae tensile testing by Green et. al.101
Testing was performed on a mechanical testing system (MTS) Synergie-100 fitted
with a 100 N load cell. Samples were preheated to 37°C in a water bath for 30 minutes prior
to testing and sample length, width, and thickness were determined using digital calipers.
Samples were placed in tensile grips lined with fine-grit sandpaper to the ends of each
sample before insertion into the MTS clamps to prevent slippage. Once samples were
secured, preconditioning (5 cycles to 10% stain at 10 mm/min), and testing to failure at a
rate of 240 mm/min was performed. Stress strain data was recorded, plotted, and collected
for statistical analysis. The tensile elastic modulus was determined from the linear region
of the graph. The UTS was determined by dividing the max peak load by the cross-sectional
area of the sample.
PATCH IMPACT RESISTANCE
Impact strength was determined in accordance with ASTM D1709 with minor
modification. Representative samples of multi-laminar angle-ply AF patches of 1, 2, 3 and
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6 layers were tested (n=4 per group). The impact mechanical test was performed to obtain
the minimum number of layers required to withstand the changes of IDP of the IVD.
Understanding the impact force is crucial due to high rapid changes in IDP which could
result in herniation’s of weaken or damaged areas of the IVD. The impact force was
determined using a custom design sled fixture consisting of four rails attached to a base
platform, with a free-moving apex platform. The testing apparatus for the tissue consisted
of two wooden blocks bolted together with a 6.25 mm diameter hole drilled through the
center of both blocks. On the inner surface of each block a neoprene square glued down
with epoxy along with a layer of sandpaper to prevent the samples from slipping during
testing. The representative samples were centered over the hole in the block and bolted
together. A 6 mm steel ball and rod was slid through the top block and placed in contact
with the tissue. The remaining rod extruded from the wooden block towards the apex of
the apparatus. Concisely, various weights ranging from 0.18-0.58 kg were dropped from a
consistent height of 10 in (0.254m) towards the base of the platform along the four rails.
The impact between the weight of the free-moving apex platform and rod were used to
measure the amount of force the patch could withstand.
Using the application of conservation of energy of a falling object EQ 1, the impact
velocity and kinetic energy were calculated. Thus, combined with the distance traveled,
impact force [N] was calculated. In conjunction to the impact force data, the contact radius
between the ball and patch was needed in order to convert to pressure. The law of
conservation of energy and the following formulas were used to calculate the contact
radius:
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Figure 6: Method of Maximum Pressure Calculations. A sphere on a flat plate (a
flat plate is a sphere with an infinitely large radius).146
This formula represents the calculated contact surface [m] of the ball with the
pericardium. F is the load [N] of the force exerted on the patch at the time of impact. R1
and R2 were the radius [m] of the ball (3 mm) and the patch (∞) respectively, where the
patch was considered a sphere with an infinitely large radius. E1 and E2 were the elastic
modulus [Pa] of the ball (200 GPa) and the patch (16.4 MPa, determined from tensile
testing), respectively. Poisson’s ratios, 𝜐1 and 𝜐2 , of the ball (0.27) and the pericardium
(0.3), respectively.7–9 Potential Energy (PE) and kinetic energy (KE) were used based on
the conservation of energy calculation to determine the impact force of a falling object.
Impact force was then converted to pressure [Pa] to relate to IDP changes (EQ. 3). The data
was collected and recorded for statistical analysis.
TENSILE FATIGUE TESTING
Mechanical tensile fatigue testing was performed on three layered multi-laminar
angle-ply patches to test the ability of the angle-ply patch to withstand 10,000 cycles of the
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UTS of the native AF tissue. The testing setup was in reference to previous fatigue testing
of Green et. al.101 Testing was conducted on a Bose ElectroForce 3200 series, model: 3220,
WinTest 7 (software), with a 100 lb. load cell. Representative samples were preheated to
37°C in a water bath for 30 minutes prior to testing and sample length, width, and thickness
were determined using digital calipers. The samples were then attached by two U-shaped
clamps with fine-grit sandpaper to prevent slippage of the material. The clamps were
submerged in a bath chamber filled with sterile PBS solution and protease inhibitor. Once
the samples were in place, the sample was aligned and brought taught to have a minimum
of 0.5 N load on the tissue prior to testing. Once the sample was secured, preconditioning
(5 cycles at 10% strain of the gauge length) was performed. Following preconditioning,
the base plate was adjusted to apply a minimum of 0.5 N load to the sample. Axial tensile
force was then applied on the patch (tension applied with alternating angles of ± 30°
oriented in the vertical axis; n=16) at a pre-determined load [N] based on the representative
percentage of UTS. Testing frequency was set at 0.5 Hz, and samples were ran until
structural failure, or completion of 10,000 cycles. One cycle consisted of raising to the
predetermined testing load with sample in tension, and lowering back down to the original
testing load. The displacement, load control value, total time, cycles performed, and where
the sample broke were recorded for statistical data analysis.
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STATISTICAL ANALYSIS
Statistical analysis of the data were performed using Microsoft Excel or statistical
analysis software (SAS Enterprise Edition 3.4, Version 9.4 or above). Results are
represented as mean ± standard error of the mean Data was analyzed using a one-way
ANOVA or by a two-tailed Student’s t-test of unequal variance with significance defined
as (p < 0.05).

50

CHAPTER III
RESULTS

PERICARDIUM SHEET FIBER ALIGNMENT AND AF PATCH ASSEMBLY
Our group has previously confirmed the decellularization of porcine pericardium
via immunohistochemistry, agarose gel electrophoresis and Nanodrop analysis
demonstrating the complete removal of alpha-Gal (porcine antigenic epitope), and a 95.3%
decrease in DNA as compared to the fresh porcine pericardium, respectively.147 This
decellularization method was utilized before construction of AF patches.
Macroscopically, parietal pericardium sheets demonstrated a fiber preferred
direction that was evident when the tissue was placed over a light box (Figure 7A).
Histology of individual decellularized pericardium sheets confirmed the composition of
the tissue (Figure 8A-B): dense regular collagen connective tissue (dense collagen type I
fibers bundled and aligned in a parallel orientation, left) fused with dense irregular collagen
connective tissue (dense arrangement of thick collagen type I fibers embedded in an
amorphous ground substance, right). The average thickness of single-ply sheets of
decellularized pericardium was 0.026 ± 0.002 mm.
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Figure 7: Fabrication of the AF patch through the alternation of individual sheets
with collagen fibers oriented at ± 30° to a common horizontal axis. A) Representative
image of a single piece of porcine pericardium. Arrows indicate collagen fiber
preferred direction within each pericardium layer, and boxes (dotted outline)
represent regions cut out for use in AF patches. B) Representative image of a 3-layer
AF patch (5 [L] x 5 [W] x 0.8 [T] mm) following patch fabrication methods. C)
Schematic representation depicting the fiber alignment in individual decellularized
porcine pericardium sheets, subsequent stacking, and suturing of sheets together.
Multi-laminate patches comprised of 2, 3, 4, and 6 layers were successfully
assembled having an average thickness of 0.05 ± 0.004 mm, 0.08 ± 0.006 mm, 0.11 mm
± 0.009 mm, and 0.16 ± 0.02 mm, respectively. The average length and width of multilaminate patches for mechanical testing and cellular studies were 12 x 12 mm and 7 x 7
mm, respectively. Predetermined by testing protocols, different patch dimensions were
constructed to fit into different test apparati. Patch sizes ranging from 4 x 4 mm to 30 x 30

52

mm were produced using our assembly method. Patches were assembled to mimic the
human AF architecture with the multi-laminate sheets of porcine parietal pericardium
aligned sequentially in alternating ± 30° to a common horizontal axis using a light box and
secured by suture (Figure 7C).
CONFIRMATION OF ANGLE-PLY ARCHITECTURE
Composition and microstructure of the AF dictate its mechanical function. Based
on the organization of collagen fibers between subsequent lamellae dictates the amount of
intradiscal pressure the AF is capable of resisting. Therefore, to develop a biomimetic
biomaterial mimicking the native AF, the resulting AF patch must be capable of presenting
fiber alignment similar to the native tissue. To evaluate the capability of aligning porcine
pericardium in alternating fiber alignment, polarized light microscopy and histology was
used to confirm the orientation of the fiber preferred direction within each layer of the
multi-laminate AF patches. Figure 8C illustrates the proof of concept demonstrating the
successful construction of a 3-layered angle-ply patch with aligned collagen fibers
orientations with the collagen fiber preferred direction running parallel to the viewer. While
the proof of concept demonstrating the alternations of individual layers was demonstrated
with the middle layer collagen fibers running parallel to the viewer, and the outer layer(s)
collagen fibers aligned coming towards the viewer. (Figure 8D).
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Figure 8: Histological analysis of decellularized porcine pericardium stained with
Masson’s trichrome (blue = collagen, red = cytoplasm), (arrow = fiber direction).
A&B) Representative single layer pericardium illustrating dense regular connective
tissue (X) and dense irregular connective tissue regions ( ), (magnification: 100X and
200X, respectively). C&D) Histological image depicting the ability to alternate the
fiber preferred orientation in additional pericardium sheets. Decellularized
pericardial sheets were aligned based on alternating the angle of the fiber-preferred
direction between each sequential layer (arrows indicate collagen fiber preferred
direction within each pericardium layer), (magnification: 100X). [C] All three layers
orientated with the collagen fiber preferred direction running parallel to the viewer,
while [D] illustrates the alternation of fiber preferred direction with the middle layer
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collagen fibers running parallel to the viewer, and the outer layer(s) collagen fibers
aligned coming towards the viewer.

ULTIMATE TENSILE STRENGTH
To determine the ultimate tensile strength (UTS) and elastic modulus (EM) of the
AF patch and to understand how fiber alignment impacts these properties, static tensile
testing was performed on 3-layered multi-laminate AF patches, as well as, single layer
sheets of pericardium. Single layer pericardium was tested in the fiber preferred (tensile
load applied parallel to collagen fiber) and cross-fiber (tensile load applied perpendicular
to collagen fiber) directions. Average UTS of a 3-layer AF patch, single layer fiber
preferred, and single layer cross-fiber testing were 5.9 ± 0.3 MPa, 5.6 ± 1.1 MPa, and 2.9
± 0.2 MPa, respectively (Figure 9). A statistical difference (p < 0.05) was found between
the UTS of three layered patches and single layer tissue oriented in the cross-fiber direction.
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Figure 9: Tensile UTS of decellularized single layer sheets and 3-layered AF patches
were tested, and values were compared to human AF (Dotted horizontal line indicates
measured human AF UTS reported in literature).101 The representative graph
illustrates the average UTS for a 3 layered AF patch and single layer sheets aligned
in fiber preferred and cross fiber directions. * indicates significant difference (p <
0.05).
EM was calculated from the linear region of the stress vs. strain graphs. Average
EM of a 3-layer AF patch, single layer fiber preferred, and single layer cross fiber were
16.4 ± 3.5 MPa, 62.0 ± 13.6 MPa, and 23.6 ± 6.0 MPa, respectively (Figure 10). A
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statistical difference (p < 0.05) was found between the EM of 3-layered patches and single
layer tissue oriented in the fiber preferred direction.

Figure 10: Tensile EM of decellularized single layer sheets and 3-layered AF patches
were tested, and values were compared to human AF lamellae (Dotted horizontal line
indicates measured human AF tensile modulus range reported in literature). 102 The
representative graph illustrates the average tensile EM calculated from the linear
region of the graph for decellularized 3 layered patch and single layer sheets aligned
in fiber preferred and cross fiber directions. * indicates significant difference (p <
0.05).
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AF PATCH RESISTANCE TO INSTANTANEOUS CHANGES OF
INTRADISCAL PRESSURE
One of the primary mechanical functions of the AF is to resist the IDP generated
by the NP. The IDP can change (increase) abruptly due to daily activities causing NP to
herniate from native AF. Thus the ability of the AF patch to resist bursting open from a
sudden increase in impact force/pressure was evaluated. The mechanical evaluation of
instantaneous change of IDP for 1-layer, 2-layer, 3-layer, and 6-layer multi-laminar patches
demonstrated an average impact resistance of < 6.81 MPa, 6.8 ± 0.0 MPa, 7.99 ± 0.22 MPa,
and 9.94 ± 0.98 MPa, respectively (Figure 11). Single layer pericardium sheet impact
resistance occurred at < 6.81 MPa, the lowest measureable amount of the custom designed
testing apparatus. A linear increase in average impact pressure was observed with
increasing layers included in the patch. Statistical difference (p < 0.05) was observed
between 2-layer and 6-layer patches, and between 3-layer and 6-layer patches.
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Figure 11: Impact resistance testing indicates multi-laminate AF patches can
withstand instantaneous application of intradiscal pressure commonly experienced in
the IVD. Representative graph of the average maximum calculated impact pressure
withstood by a 2-, 3-, and 6-layer patches. (Dotted horizontal line indicates highest
measured in vivo human IDP reported in literature [2.3 MPa observed while bent
over with a round back while lifting 20 kg.]) * indicates significant difference (p <
0.05).

Previous testing conducted in our lab was conducted to determine the quasi-static burst
strength of AF multi-laminate patches.147 The burst strength testing protocol was adapted
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from the ASTM D3786/D3786M: Bursting Strength of Textile Fabrics Method. The
mechanical evaluation of the burst strength was performed for 1-layer, 2-layer, 3-layer, and
6-layer multi-laminar patches demonstrated an average impact resistance of at 4.26 ± 0.40
MPa, 7.53 ± 0.52 MPa, 10.75 ± 1.47 MPa, and 18.49 ± 0.76 MPa for, respectively (Figure
12).147 Statistical difference (p < 0.05) was observed between all testing groups.

60

*
*
*
*

Figure 12: Burst resistance testing indicates multi-laminate AF patches can withstand
quasi-static application

of

pressure commonly

experienced

in

the IVD.

Representative graph of the average maximum calculated burst pressure for 1-, 2-, 3, and 6-layer patches. (Dotted horizontal line indicates highest measured in vivo
human IDP reported in literature [2.3 MPa observed while bent over with a round
back while lifting 20 kg.]) * indicates significant difference (p < 0.05). Picture
reproduced with permission of R. McGuire.147
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DYNAMIC TENSILE FATIGUE TESTING
One of the two primary spinal motions in the lumbar region is flexion. The bending
motion associated with flexion is resisted by the posterior annulus and posterior
longitudinal ligament. The ability of the AF patch to resist varying stress amplitudes during
tensile fatigue loading was evaluated. Dynamic tensile fatigue testing of 3-layered multilaminate AF patches was performed to predict the relative lifespan/endurance of the patch.
Representative samples were tested to a mechanical run out of 10,000 cycles over a range
of stress amplitudes observed during flexion to develop an S-N curve. Testing was
conducted at stress amplitudes ranging between 0.95-2.66 MPa (25-70% UTS of the native
human AF). AF patches withstood at minimum 1155 ± 75 cycles and achieved an
endurance limit of 10,000 cycles at stress amplitudes of 2.66 MPa and 0.95 MPa,
respectively. The S-N curve (Figure 13) illustrates the recorded data for AF patch overlaid
on values reported for human AF tested under the same conditions. Supplemental data of
Detailed applied load and cycles to failure of cyclic tensile fatigue experiments are listed
in (TABLE 6).
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Figure 13: Tensile fatigue endurance of 3-layer AF patch approximates that of the
native human AF. S-N Curve illustrating the fatigue strength of our 3-layered multilaminate AF patch (triangles), in comparison of native human AF (diamonds).101 A
negative correlation between the level of applied stress and the number of loading
cycles to failure was observed. Open diamonds, triangles, and arrows indicate
specimens with no mechanical failure observed (mechanical run out to 10,000 cycles).
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Table 6: Detailed applied load and cycles to failure of cyclic tensile fatigue
experiments with native AF (left) vs. 3-layered multi-laminate AF patch (right) based
on representative UTS (Ultimate Tensile Strength) percentages. Tests were halted
following a mechanical run out to 10,000 cycles.
Loading Details
7

Native AF
Load (% UTS) Load (MPa) Cycles to failure
41
1.56
10000
46
1.75
10000
47
1.79
1835
49
1.86
10000
54
2.05
10000
54
2.05
10000
55
2.09
14
56
2.13
1860
59
2.24
371
59
2.24
4245
61
2.32
5
63
2.39
15
63
2.39
960
64
2.43
215
64
2.43
2720
65
2.47
27
68
2.58
700
71
2.70
195
91
3.46
5

Multi-layered AF Patch
Load (% UTS) Load (MPa) Cycles to failure
50
1.90
3740
50
1.90
7810
50
1.90
4590
45
1.71
2200
45
1.71
5630
45
1.71
5350
25
0.95
10000
26
0.99
10000
60
2.28
2350
30
1.14
10000
40
1.52
10000
60
2.28
1850
70
2.66
1230
70
2.66
1080

CELLULAR ANALYSIS
Cellular studies were conducted on 3-layered multi-laminate angle-ply AF patches
to ensure cell viability on all layers of the patch. Previous laboratory testing showed that
bovine AFCs were viable on the surfaces of the patches through day 15 studies;147 however,
following histological analysis cell viability between the upper and lower layers were
previously unidentifiable. To provide the greatest chance of probability of cell attachment,
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a volume optimization protocol was used to determine the total amount of volume (µl of
cell culture media containing AF cells) an AF patch was capable of holding to prevent runoff. It was determined a 7 x 7 x 0.8 mm3 AF patch was capable of holding 45 µl on the top
and bottom layers, and 75 µl between the layers before run-off occurred.
Tissue disruption modification (sonication) was used with the hypothesis of
disrupting the tissue extracellular matrix to provide more nutrient transfer to the inner
layers. Histological analysis of representative control and sonicated 3-layered multilaminate AF patches of days 3 and 6, respectively, illustrated cell attachment and
infiltration (Figure 14). Histological evaluation illustrates AF cell attachment on all layers
of the multi-laminate AF patch for all samples and time points investigated.
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Figure 14: Multi-laminate AF patches support AF cell viability, and infiltration
demonstrated through stained H&E (purple = cellular nuclei, pink = ECM) samples.
A-B) Representative histological cross-sectional images depicting the presence of AF
cells within the tissue of a 3–layer multi-laminate AF patch at days 3 and 6 stained
with H&E (magnification: 100X). C-D) Representative cross-sectional histological
images depicting the presence of AF cells within the tissue of a 3–layer multi-laminate
sonicated AF patch at days 3 and 6 stained with H&E (magnification: 200X and 50X,
respectively).
Representative sections of day 6 AF patches for sonicated and controlled tissues
were magnified to perceive clearly the cells infiltrated into the tissue (Figure 15). The
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width of the representative tissue layers were measured and recorded at 538 µm and 483
µm (Table 7). Average measured cell penetration depths for sonicated and control sample
AF patches, measured using ImageJ software, were 278 µm and 52 µm, respectively. The
furthest depth of cell infiltration were 503 µm (93.7% overall depth relative to tissue width)
and 327 µm (67.7% overall depth relative to tissue width). A statistical difference (p <
0.05) was observed between the average cell infiltrations of sonicated and control patches
on day 6.

Figure 15: Increased magnification of a multi-laminate AF patch section, one of the
three layers, depicting infiltration of cells into the tissue layers for day 6 sonicated
and controlled AF patches. (Left) Sonicated tissue treated for 20 minutes at time point
day 6. (Right) Control tissue at time point day 6. (Left and Right original
magnification: 200X).
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Table 7: Measurement and analysis were conducted to illustrate cell infiltration. To
determine the depth of penetration by the AF cells H&E histological staining and
ImageJ software were used. Representative sections of a 3-layered multi-laminate AF
patch were magnified (Figure 9) to perceive clearly the cells for sonicated and control
tissue samples. Width of the representative tissue layers were measured, and
average/deepest depth of cell infiltration was analyzed for sonicated and control tissue
samples, respectively. For average and deepest cell infiltration, the percentage of
overall depth relative to tissue width is displayed in parenthesis. * indicates significant
difference (p < 0.05).
Day 6 (AF Patch) Cell Infiltration Measurement
Sonicated

Control

Width of Layer

538 µm

483 µm

Average Cell Infiltration*

278 µm
(51.7%)

52 µm
(10.7%)

Deepest Cell Infiltration

503 µm
(93.5%)

327 µm
(67.7%)
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CHAPTER IV
DISCUSSION
Effective biological AF repair is an unmet clinical need for several applications: to
prevent recurrent IVDHs, to preserve the IVD biological structure and functionality, and/or
to support NP arthroplasty devices for patients with early stage interventions targeting
IVDD. An ideal AF repair device must mimic the biological, structural, and functional
characteristics while promoting tissue regeneration. The native AF is comprised of highly
organized lamellae of aligned type I collagen fibers. When entirely intact, the AF confines
the NP to the center of the IVD and provides resistance to IDP generated by the NP. When
a defect is present, the associated underlying pathology and surgical repair typically
contribute to long-term pain and long-term effects on adjacent IVDs (adjacent segment
degeneration).
Until recently, clinicians believed pain associated with IVDH would resolve on its
own without surgical intervention (i.e. spontaneous resorption of the herniation). However,
despite a temporary reduction in pain, a recent study indicated when herniations were left
untreated, a resurgence of pain occurs.50 For patients presenting with radicular symptoms
or low back pain that is unresponsive to conservative therapy, and demonstrate through
magnetic resonance imaging (MRI) or computed tomography (CT) confirmation of an NP
herniation or extrusion, a discectomy procedure is often warranted.148 Annually, there are
over 500,000 lumbar discectomies performed in the United States.50 While this procedure
yields satisfactory clinical outcomes, an open pathway (defect) remains which provides a
path of least resistance for recurrent IVDHs to manifest. It has been shown, the rate of re-
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herniation is greater in patients with an AF defect larger than 6 mm.10,149 The wide variety
of approaches and techniques used to perform a discectomy can be debated with respect to
their advantages and disadvantages. While a less aggressive discectomy approach
(removing the protruding NP fragment without an extensive intradiscal compression)
results in improved patient outcomes, it does present a greater risk for re-herniation as
compared to an aggressive approach (removal of more than the protruding NP tissue [disc
decompression] in attempts to decrease the likelihood that re-herniation may occur).54
Therefore, an effective AF closure/repair device in conjunction with a less aggressive
discectomy may result in improved patient outcomes, decreased pain, and fewer revision
surgeries via lower re-herniation rates.5,6 Additionally, with the application of an AF
closure device, it could lead to a reduction of chemical pain mediators escaping through
the open AF following a conventional discectomy, thus reducing the effects of irritation of
the nerve root ganglion, epidural fibrosis, or the potential for ingrowth of nerve fibers that
are mediators of postoperative discogenic pain.150–152
The discectomy procedure itself is not benign to the disc – it is an ablative, not a
restorative procedure.148 Suturing is a simple and appealing repair method to be used for
AF closure due to its frequent use during surgery; however, suturing does not account for
missing AF tissue and may not be strong enough to resist changes in intradiscal pressure
(IDP).5,6,16 Therefore, there has been an increase in tissue engineering and regenerative
therapeutic being investigated over the last decade aiming to structurally and biologically
repair the AF.
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A need exists to develop an AF closure/repair device that mimic the architecture
(multi-laminate lamellae of aligned collagen oriented in an angle-ply fashion), mechanical
properties (ultimate tensile strength and modulus), cytocompatibility (ability to promote
cell viability and regeneration), and function (ability to resist tensile loading, intradiscal
pressures, and fatigue) of the native human AF. The objective herein was to confirm our
ability to generate multi-laminate patches comprised of decellularized porcine pericardium
with a repeatable angle-ply architecture, to mechanically evaluate their strength and
durability, and assess their cytocompatibility. It is hypothesized that the AF patches
composed of decellularized porcine pericardium would mimic the biological, structural,
and functional characteristics of the native AF, and therefore, be an ideal surrogate for use
in its repair.
PATCH FORMATION

The development of the biomimetic AF patch that mimics the native human AF
architecture was vital. The alternation of collagen fibers between the native lamellae is the
underlying foundation of what provides the AF strength when distributing the tensile
bending and torsional forces throughout the functional spinal unit.153 The parietal
pericardium layer from porcine hearts was chosen due to its natural underlying structure.
The parietal pericardium is fused to and inseparable from the fibrous pericardium (most
superficial layer of the pericardium). It consists of dense and loose connective tissue
comprised of collagen type I,143 mimicking the native composition of the AF. The dense
connective tissue is divided into regular and irregular sections. Dense regular connective
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tissue contains collagen type I fibers bundled in a linear/parallel orientation. The presence
of these collagen fibers was utilized during fabrication of the scaffold.

By manually alternating the fiber preferred direction of the dense regular fiber
architecture of the decellularized porcine pericardium over a light box, a repeatable method
to overlay consecutive sheets of pericardium achieving an angle-ply orientation was
developed. Following the alignment of subsequent layers, the patches were secured
together using suture. The simplicity of this technique combined with the need for different
sized patch dimensions for testing protocols, patient IVD height, and varying patient AF
defect sizes allowed for the construction of patches ranging in size from 4 x 4 mm to 30 x
30 mm using our assembly method. The mean disc height reported for the lumbar segment
of the spine were 11.6 ± 1.8 mm for the L3/4 disc, 11.3 ± 2.1 mm for the L4/5, and 10.7 ±
2.1 mm for the L5/S1 level.154 While not surprisingly, the size of an AF defect exhibits an
enormous effect on the re-herniation rate. In patients with massive AF defects (> ~6-6.5
mm), the re-herniation rate was 27% compared to patients with slit defects who
experienced re-herniation rates of only 1%.10 Thus, based on these results, it would indicate
that if larger defects are effectively reduced in size, re-herniation rates could fall
dramatically in this “at-risk” group of patients.148 Taken together, we were able to produce
patch sizes that are of clinical utility. In addition, the development method employed to
make these patches can be easily scalable for batch manufacturing procedures compared
to other formation methods of AF scaffolds which require more complex manufacturing
techniques.155
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CONFIRMATION OF ANGLE-PLY ARCHITECTURE
Verifying the proof of concept creating an angle-ply AF patch architecture was
demonstrated through histological images of single sheets and three layer stacking.
Masson’s trichrome staining and polarized light microscopy was used to view the fiber
preferred direction histologically. Polarized light microscopy was used to refract the light
based on collagen fiber orientation within the individual layer of pericardium. Since
collagen fibers are an anisotropic material, it expresses birefringent under polarized light.
With this optical property, the fiber preferred direction of the porcine pericardium were
clearly visible to correspond to the fibers seen macroscopically. When stacked in multiple
layers, the AF patch demonstrated the proof of concept for the alternation of fibers with
the collagen fibers visible in the individual layers aligned coming towards the viewer, and
the alternating layers oriented away from the viewer.
MECHANICAL TESTING OF AF PATCH
Of the available repair methods for AF regeneration, decellularization of an
extracellular matrix derived scaffold is an attractive option due to its ability to promote the
expression of M2 macrophages (immune cells with the ability to promote tissue
homeostasis through cell proliferation and tissue repair)156 and its ability to preserve the
tissues microenvironment.157 In addition, these attributes promote cell survival,
proliferation, morphogenesis, differentiation, and constructive tissue remodeling.158,159
However, the decellularization process of a biological tissue can have potentially
significant effects on the biomechanical properties of the resulting scaffold. Thus, it is
critical to evaluate how closely the mechanical characteristics of the resultant AF patch
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compare to the values of the native human AF. Although the mechanical advantage of
closing annular defects to retain NP material seems intuitive, only recently have AF closure
devices been examined for their ability to withstand in situ IDP or flexibility testing.16 For
this reason, it was paramount to evaluate the mechanical characteristics of our multilaminate angle-ply AF patches with respect to tensile strength, impact resistance, and
tensile fatigue.
UTS TESTING
To characterize the maximum tensional stress our AF patch is capable of resisting,
representative samples were placed under a static tensile load to develop a stress-strain
relationship. These values were then compared to reported human AF tissue to approximate
the maximum tensile loads endured by the AF during flexion/bending. The AF patch
illustrated mechanical properties of UTS and elastic modulus (EM), which fell within the
reported values of the native human AF (3.8 ± 1.9 MPa, and 12-24MPa,
respectively).101,102 The biological function of a collagen-based material lies predominantly
in its mechanical properties. The viscoelastic biological tissue (combined with strong
underlying cross-linking fibers)160 expressed both viscous and elastic properties when
undergoing deformation. This particular behavior results from the anisotropic
microstructure of the AF tissue composed of oriented collagen fibers embedded in the
ECM.
The measured UTS represents the maximum stress that the material could withstand
before failing, and is correlated with the highest stress value on the stress-strain graph.
Collagen fibers have the optical property of birefringence that defines the direction they
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can bear a load in a tissue, and the strength of birefringence has been correlated with the
UTS.161 In a stress-strain relationship, the EM is calculated from the linear portion of the
graph up to the yield point of the material. As a material stiffness increases it expresses a
higher EM. The low EM of the AF patch demonstrates its flexibility and ability to change
shape while maintaining a relatively high UTS similar to the native AF tissue.
The UTS and EM of the single layer fiber preferred direction were shown to be
greater than the single layer cross-fiber direction. This is attributable to the mechanical
function of the collagen fibers that work to resist tension, and while applying a load
perpendicular to or at an angle from the primary axis of the fiber preferred direction would
essentially cause the interstitial matrix to endure the majority of the stress, not the fibers
themselves. The difference seen between the fiber preferred and cross-fiber directions is
also consistent with acellular scaffolds and continuous fibers in composite materials
consisting of predominantly collagen fibrils. These acellular scaffolds and continuous
fibers demonstrated the mechanical properties of the fiber preferred orientation and
resulted in higher tensile strength and stiffness (elastic modulus) compared to that of the
cross-fiber preferred direction.162,163
Analysis of tissue behavior increases in complexity as the hierarchical tissue
structures become more complicated. The AF patch (aligned with ± 30° alternations
between subsequent layers) expressed higher UTS compared to single layer tissue aligned
in the fiber preferred direction and cross-fiber direction. This is consistent with mechanical
testing of angle-ply laminates which found that opposing (± 30°) constructs were stronger
than the fiber preferred aligned constructs.132 While another study showed that during
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uniaxial tensile loading on various fiber angles, the elastic moduli varied with a nonlinear
decrease seen in modulus with increasing fiber angles.120
Even though axial rotation and lateral bending in the lumbar discs are relatively
limited, the range of motion of the IVD in flexion-extension can be as high as 24 degrees.164
Because the center of rotation of the disc is typically anterior of the posterior AF, the strain
range of the posterior AF during these high ranges of motion can vary greatly. Maximal
physiologic strains observed along the AF superficial tissue are about 4% when the disc is
in compression or torsion, and ~6% when the disc is in flexion or extension, but never
exceeding 10%.165 Thus, designing a device that can maintain its integrity while sealing
defects that also go through this strain range is extremely challenging.148 The amount of
strain experienced to reach the UTS of our AF patch, relative to the native AF tissue UTS,
was 5.7 ± 0.43 mm. Thus demonstrating the ability of our AF patch to undergoing the
native strain range, while maintaining its tensile strength integrity.
FATIGUE TESTING
To assess the capability of the AF patch withstanding dynamic loading, the AF
patch underwent tensile fatigue testing for ranges of 25-70% UTS. Upon characterizing the
UTS of the AF patch, it was necessary to address the levels of stress amplitude commonly
experienced by the AF during flexion. The representative testing range, of 25-70%, was
performed based on the lower range limit determined from the resulting endurance limit of
the AF patch. While the upper range limit was chosen to be 70% (due to the fact, when
placed in vivo, the IVD is unlikely subjected to stresses higher than 70% UTS due to the
prevention of injury by ligaments of the neural arch during extension and lateral bending,
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and through soft tissues during flexion).166 Comparative analysis of the AF patch and native
human AF, illustrated by Figure 7, demonstrates the AF patches display of a similar S-N
curve profile relating the level of applied stress to the number of loading cycles withstood
prior to failure.
Adapted from a previously published testing protocol for AF tensile fatigue
testing,101 10,000 cycles were chosen for the mechanical run out of our AF patch. This was
not to represent a true fatigue limit, but an estimation of how a biological tissue will last in
a theoretical environment absent of intrinsic healing. While the AF is constantly subjected
to cyclic tensile loading, typically the higher maximum tensile stresses only occurs during
a limited range of motions, such as bending forward at the waist (without bending your
knees), sitting down in a low chair, or tying your shoes. When damage to the AF does
occur, the intrinsic healing process begins. The AF is identified to heal in three phases: 1st
phase is when the outer AF begins to heal (day 0 – few weeks), 2nd phase is when the
interior AF layers gradually heal (few weeks – one-year), and 3rd phase is when there is an
increase of collagenous fibers within the NP.112 Based on the tensile fatigue results, the
AF patch has the capability to resist failure for between 1.0-2.7 years (conservatively
assuming achievement of maximal flexion approximately 10-25 times per day), which is
beyond the reported time required for native AF healing (which would eventually help offload the mechanical patch responsibilities).112 Therefore, it is reasonable to assume that
when placed under tensile loading the AF patch is capable of meeting the mechanical
demands experienced during flexion for the posterolateral AF.
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IMPACT TESTING
Impact mechanical testing was performed to obtain the minimum number of layers
required to withstand the changes of IDP generated by the NP of an IVD. Currently, IDP
measurement is the only direct way to determine the loading conditions within the human
spine.48 The posterior region of the AF is inherently weaker due to its more parallel
alignment to the horizontal axis of the spine compared to other regions.29 Combined with
instantaneous changes of IDP within preceding IVDH defects and/or discectomy procedure
sites provide a weakened region in the AF lamellae that have been linked to the rupture of
the AF; therefore, it was crucial to characterize the impact resistance for the AF patch.167
The AF patch must be capable of enduring the maximum impact force generated by the NP
since the vacant area beneath the patch will represent the entire thickness of the AF in the
repaired region.
Previously reported by our group, the quasi-static burst strength of the AF patch
was calculated to determine the approximate amount of layers required to withstand typical
IDP values generated by the NP.147 While herniations typically occur from a gradual
degeneration of the disc (weakening of the posterior AF), the rate of IDP change varies
based on AF tissue degradation and movement of the patient. Currently, no published
studies specify the speed at which a herniation occurs in nondegenerated IVDs. Using
calculations based on the reported IDP ranges seen in the native human AF, (0.1-2.3
MPa),167–169 combined with the idea that an instant change of force can lead to an increase
in stress concentrations, the AF patches were tested at varying forces with a constant
velocity of 2.23 m/sec. This velocity is consistent with compression testing conducted to
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measure the failure mechanisms of the impact loading on the spine,170,171 and represent
greater speeds than are commonly tested for physiological responses to impact loading.172–
174

The impact resistance measured of AF patches indicated its ability to withstand

instantaneous changes of IDP observed within the human IVD. A linear increase in average
impact resistance was observed with increasing the number of pericardium layers within
the AF patch. While theoretically, the amount of layers required to withstand instantaneous
changes in IDP commonly observed was less than three layers (optimized value chosen for
the AF patch), previous results from the quasi-static burst strength testing illustrated a need
for the minimum of 3-layers. Additionally, this impact mechanical testing does not account
for repetitive cyclic increases in IDP which would be seen in vivo. Future studies will be
conducted to measure the efficacy of the patch to resist cyclic IDP and containment of the
NP material through dynamic compression fatigue resistance testing, following attachment
to cadaveric IVDs.
CYTOCOMPATIBILITY OF CELL SEEDING ON AF PATCH
Aside from the AF patch having mechanical characteristics that closely
approximate the human AF, it is also made of a biologic material that may lead to the
promotion of tissue regeneration. This is something that cannot be said about synthetic AF
repair techniques/materials. The regenerative potential the biological AF patch possesses
is an advantage in the way it will aid in self-repair and integration. Following attachment
of the AF patch to the native IVD, the entire mechanical load is supported by the
biomaterial scaffold and attachment mechanisms. Thus, the patch must maintain sufficient
mechanical strength to support physiological loading. With the potential increase of

79

integration between the AF patch and native AF tissue over time, the applied loads on the
patch will decrease; thus, assisting in the durability of the AF patch and attachment
mechanism. It is reported that AF regeneration could potentially be enhanced by the
supplementation of cells to accelerate the healing process of large annular defects.130 While
this is not essential as a mechanical surrogate, the AF patch should be capable of, at the
minimum, supporting cell viability of cells within the patch as well as potentially promote
the migration of neighboring cells into the patch.
Tissue engineering scaffolds are developed to influence the physical, chemical, and
biological environment surrounding a cell population.175 The use of cells affects the
scaffolds ability to regenerate the ECM by maintaining the long-term homeostatic balance
of matrix turnover.176 Therefore, cytocompatibility studies were conducted to evaluate the
AF patch ability to allow for cell infiltration of viable AF cells. Bovine AF cells were used
in the current study to test for cytocompatibility of the AF patch with cells representing an
end-stage phenotype found in the native AF. While bovine AF cells were suitable for
studying the effects of cell behavior on the AF patch, there is a need for an alternative cell
source if it is to be used in a clinical setting. Allogenic AF cell isolation requires the patient
to be subjected to an invasive surgical procedure, and xenogeneic AF cells are not a viable
option. Therefore, the use of stem cells integrated within the AF patch during implantation
needs to be investigated to identify potential improvement for regeneration capabilities of
the patch. This will be addressed in future studies.

The previous testing conducted in our lab demonstrated the viability of AF cells on
the outer layers of the AF patch; however, histologically cells were not observed within
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the inner layers.147 It was assumed that the cells seeded on the inner layers may have
undergone premature cell death and detached before histological analysis was conducted
due to the dense ECM preventing the nutrient transfer. However, the current study
presumed that a non-optimized cell seeding process could have contributed to the failure
of cells attaching to the inner layers. Therefore, a cell suspension volume optimization
protocol was developed to ensure cell seeding accuracy. Additionally, ultrasonication
studies were conducted with the intent of disrupting the ECM of the AF patch layers in
order to improve nutrient transfer and cell migration within the inner layers of the AF patch.

The results indicated the AF patch does allow for the attachment and infiltration of
AF cells in all three layers for an extended period, and is capable of supporting cell
viability. This was true for both the control (non-sonicated) samples and sonicated samples.
While the volume optimization protocol ensured cell attachment on the inner layers of the
AF patch was feasible without tissue disruption, sonicated samples showed a statistical
difference in the distance cells were capable of infiltrating into the tissue; however,
sonication treatment of the AF patches could also potentially weaken mechanical
properties.
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CHAPTER V
CONCLUSIONS & RECOMMENDATIONS FOR FUTURE STUDIES
Coupled with our previously reported findings that illustrate the simplicity and
scalability of our patch formation method concurrent with its ability to support AF cell
attachment, these mechanical testing data suggest our AF patch is an ideal surrogate to
replace and regenerate the native human AF tissue. Overall results show similar mechanical
properties to native human AF tissue through the ultimate tensile strength and elastic
moduli, the ability to resist instantaneous changes of IDP, and strength to withstand tensile
fatigue mimicking the intact (15-25 layer) native human AF. Thus, our device could
improve patient outcomes and lower healthcare costs for those with IVDH by allowing for
the utilization of less aggressive discectomy, minimizing the reoccurrence of IVDH, and
may allow the use of early-stage interventions including nucleus arthroplasty for those with
IVDD. Future studies should include burst fatigue strength, animal studies, and further
cellular characterization studies (stem cell seeding, GAG content, and cross-linking
between the layers).
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